Nonalcoholic fatty liver disease

NAFLD

non-alcoholic fatty liver disease: A term referring to fatty replacement of the hepatic parenchyma which is not related to alcohol use.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K76.0 Cause of death: ICD-10 — K76.0 2 out of 7 registries used, show all original rules.	4847
4. Check minimum number of events None	4847
5. Include endpoints None	4847
6. Filter based on genotype QC (FinnGen only)	4331

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K76
Name in latin: Degeneratio adiposa hepatis non alibi classificata

NAME	NAFLD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K760
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K760
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Nonalcoholic fatty liver disease based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	18945	9005	9846
Only index persons	18156	8715	9441
Unadjusted period prevalence (%)
Whole population	0.27	0.26	0.28
Only index persons	0.34	0.32	0.36
Median age at first event (years)
Whole population	52.61	56.47	49.12
Only index persons	52.46	56.38	48.84

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4331	2475	1856
Unadjusted period prevalence (%)	0.87	0.88	0.85
Median age at first event (years)	55.86	56.60	54.88

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4514: Matched controls
45140

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A10BA02

ATC

metformin; oral

4.5

307.7

2181

7770

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

17.2

307.7

315

196

A10BJ06

ATC

semaglutide; parenteral

5.6

307.7

689

1396

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

4.6

307.7

1914

6211

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

5.7

307.7

764

1566

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

12.0

307.7

457

419

E66.01

ICD-10 Finland

Obesity due to excess calories

4.5

307.7

1023

2742

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4503599627370496.0

307.7

4512

261

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

5.8

307.7

1094

2351

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.3

307.7

1981

7011

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

5.6

307.7

700

1443

E11

ICD-10 Finland

Type 2 diabetes mellitus

3.9

307.7

1271

4078

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

14.9

307.7

519

389

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

28.8

307.7

412

157

K76.9

ICD-10 Finland

Liver disease, unspecified

17.7

307.7

359

219

103

Kela drug reimbursment

Diabetes, insulin-treated

4.2

307.7

2024

7264

T90

ICPC

Diabetes non-insulin dependent

4.2

307.7

1927

6789

E66.00

ICD-10 Finland

Metabolic syndrome

6.2

307.7

735

1371

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

29.1

283.9

190

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.9

253.4

1835

8577

A10BK03

ATC

empagliflozin; oral

3.9

253.0

869

2585

A10BH01

ATC

sitagliptin; oral

4.2

252.6

762

2064

E66.8

ICD-10 Finland

Other obesity

4.7

238.6

616

1477

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.9

234.8

797

2344

G47.3

ICD-10 Finland

Sleep apnoea

2.7

205.9

1631

7819

A10AE04

ATC

insulin glargine; parenteral

3.7

200.8

728

2226

I10

ICD-10 Finland

Essential (primary) hypertension

2.6

194.9

3048

19989

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.1

184.3

926

3456

A10BJ02

ATC

liraglutide; parenteral

5.7

173.0

335

622

A10BG03

ATC

pioglitazone; oral

6.5

151.0

253

407

SPAT1262

SPAT

Handing over of treatment supplies

2.7

150.5

987

4213

A10BK01

ATC

dapagliflozin; oral

3.5

149.7

587

1871

R94.5

ICD-10 Finland

Abnormal results of liver function studies

7.9

148.9

209

277

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

10.2

147.9

168

170

N02AX02

ATC

tramadol; systemic, rectal

2.2

138.8

2271

14344

C03DA01

ATC

spironolactone; oral

3.0

133.8

688

2569

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.4

133.6

1279

6475

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

12.0

130.1

132

113

C03CA01

ATC

furosemide; systemic

2.3

129.8

1246

6303

T82

ICPC

Obesity

3.9

124.1

384

1040

A02BC02

ATC

pantoprazole; systemic

2.3

122.9

3382

25599

A10BJ05

ATC

dulaglutide; parenteral

5.9

119.3

221

392

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.7

116.3

708

2879

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.3

115.5

1078

5353

C08CA01

ATC

amlodipine; oral

2.1

114.6

1826

11181

E66.9

ICD-10 Finland

Obesity, unspecified

4.2

114.4

322

813

UJF32

NOMESCO Finland

Coloscopy

2.2

113.6

1356

7440

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

110.3

1913

12034

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

108.4

2283

15343

R5140

NOMESCO Finland

Monitoring the use of the aid

2.6

107.3

731

3135

C07AB07

ATC

bisoprolol; oral

2.0

102.7

2172

14524

A10AB05

ATC

insulin aspart; parenteral

3.0

102.4

493

1761

205

Kela drug reimbursment

Chronic hypertension

2.2

102.2

1107

5809

E66

ICD-10 Finland

Obesity

3.2

101.3

444

1502

H02AB06

ATC

prednisolone; systemic

1.9

99.9

2335

16096

D97

ICPC

Liver disease NOS

13.5

99.0

A10BH05

ATC

linagliptin; oral

3.9

97.7

304

824

R03AC02

ATC

salbutamol; inhalant

1.9

97.0

2728

19911

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.9

95.9

300

816

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.0

95.8

148

218

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.5

92.7

668

2929

K74.0

ICD-10 Finland

Hepatic fibrosis

24.4

91.6

M04AA01

ATC

allopurinol; systemic

2.6

89.2

605

2575

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

12.7

87.2

A10BB12

ATC

glimepiride; oral

3.5

86.9

320

970

E83.1

ICD-10 Finland

Disorders of iron metabolism

11.2

85.0

UJF30

NOMESCO Finland

Ileoscopy through colon

2.4

83.9

633

2827

Z3231

NOMESCO Finland

Registered nurse

1.9

79.9

1317

7946

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.4

79.8

204

477

OAB50, ,

SPAT

2.6

79.3

497

2030

R06.0

ICD-10 Finland

Dyspnoea

1.9

77.5

1287

7769

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.2

76.8

213

530

160

Kela drug reimbursment

exenatide

4.8

75.8

173

369

A02BC05

ATC

esomeprazole; systemic

1.8

73.4

1971

13734

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

72.7

718

3582

A05AA02

ATC

ursodeoxycholic acid; oral

5.2

72.1

151

299

C10AA05

ATC

atorvastatin; oral

1.8

71.6

1889

13071

C10AA01

ATC

simvastatin; oral

1.8

70.6

1616

10717

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

69.7

729

3715

XCK10

NOMESCO Finland

Photography of fundus of eye

2.5

69.7

474

2010

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.2

69.4

634

3061

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

68.6

714

3630

R4110

NOMESCO Finland

Physiotherapy

1.8

68.3

1343

8494

Z3226

NOMESCO Finland

Physiotherapist

2.0

68.1

892

4937

N06AX16

ATC

venlafaxine; oral

2.1

67.7

813

4360

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

66.1

1233

7660

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.5

66.0

166

383

N06AX11

ATC

mirtazapine; oral

1.8

65.8

1648

11163

A07EA06

ATC

budesonide; oral, local oral

3.3

65.8

258

812

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

65.7

604

2919

L04AX01

ATC

azathioprine; systemic

3.1

65.5

286

960

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

64.5

1062

6334

M79.6

ICD-10 Finland

Pain in limb

1.7

64.5

2143

15659

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

64.3

1204

7476

N03AX16

ATC

[U] pregabalin

1.9

64.3

1127

6856

R4190

NOMESCO Finland

Nutritional therapy

3.1

64.0

274

909

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.9

62.8

306

1093

M10.9

ICD-10 Finland

Gout, unspecified

2.8

62.7

344

1309

K76.89

ICD-10 Finland

Other specified diseases of liver

14.5

62.2

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

61.7

3402

28376

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

12.7

61.5

A10AE05

ATC

insulin detemir; parenteral

2.9

61.4

306

1106

Z2221

NOMESCO Finland

Medical doctor

1.8

61.2

1257

8005

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

60.1

405

1705

A10BX07

ATC

[U] liraglutide

5.6

59.9

114

207

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

59.1

933

5471

J01FF01

ATC

clindamycin; systemic

1.8

58.9

1297

8414

L17

ICPC

Foot/toe symptom/complaint

1.7

58.8

1458

9777

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.3

57.7

117

225

K70.0

ICD-10 Finland

Alcoholic fatty liver

7.2

57.1

120

R18

ICD-10 Finland

Ascites

4.4

57.1

145

337

A10BD07

ATC

metformin and sitagliptin; systemic

3.1

57.0

248

830

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

56.4

1445

9754

ZXE00

NOMESCO Finland

One hour or less

1.7

56.0

1715

12131

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.7

55.7

323

1263

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

55.2

466

2167

C10AC01

ATC

colestyramine; oral

3.7

55.0

182

513

A07EC02

ATC

mesalazine; oral, rectal

2.7

54.8

324

1279

K74.3

ICD-10 Finland

Primary biliary cirrhosis

8.6

54.2

162

Kela drug reimbursment

liraglutide

5.6

54.1

103

187

R02

ICPC

Shortness of breath/dyspnoea

2.0

54.0

633

3345

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

53.7

1305

8659

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

53.7

910

5439

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.1

53.6

614

3217

OAB72

NOMESCO Finland

Weight control and weight loss guidance

5.8

53.2

169

C08CA13

ATC

lercanidipine; oral

2.0

53.1

655

3524

WX002

NOMESCO Finland

Sedation and analgesia

1.9

53.0

863

5092

JJA20

NOMESCO Finland

Open biopsy of liver

14.3

52.8

K72.9

ICD-10 Finland

Hepatic failure, unspecified

10.5

52.6

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

52.5

520

2578

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

52.4

281

1055

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

6.2

52.4

148

A10AC01

ATC

insulin (human); parenteral

2.5

52.3

353

1485

P06

ICPC

Sleep disturbance

1.9

52.0

707

3930

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

6.4

52.0

136

WX402

NOMESCO Finland

General anaesthesia

1.7

51.9

1131

7272

N05AH04

ATC

quetiapine; oral

1.8

51.5

883

5288

H03AA01

ATC

levothyroxine sodium; systemic

1.8

51.4

1056

6672

J01DB01

ATC

cefalexin; oral

1.9

51.2

3778

33105

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

51.0

1560

10964

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

50.9

1934

14337

C09CA01

ATC

losartan; oral

1.7

50.5

1125

7267

J01MA02

ATC

ciprofloxacin; systemic

1.6

50.4

1670

11966

N06AX21

ATC

duloxetine; oral

2.0

50.3

644

3504

C09AA02

ATC

enalapril; systemic

1.9

50.0

753

4327

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

49.8

1094

7036

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

49.7

1416

9760

Z71.8

ICD-10 Finland

Other specified counselling

1.6

49.6

1609

11457

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

4.2

49.1

134

329

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

48.9

627

3412

C10AA07

ATC

rosuvastatin; oral

1.6

48.2

1601

11444

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

47.9

2030

15366

M54.5

ICD-10 Finland

Low back pain

1.6

47.8

1750

12798

R11

ICD-10 Finland

Nausea and vomiting

2.2

47.5

433

2073

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.7

47.0

261

997

J01MA12

ATC

levofloxacin; systemic

1.8

47.0

806

4815

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.3

46.9

123

293

A46

ICD-10 Finland

Erysipelas

1.9

46.9

658

3688

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

11.0

46.8

D07AC01

ATC

betamethasone; topical

1.6

46.7

1656

12003

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

46.4

1613

11630

N06AB04

ATC

citalopram; systemic

1.7

46.3

956

6028

H02AB07

ATC

prednisone; oral

1.9

46.2

619

3414

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.1

45.8

127

316

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

45.6

2602

20984

S18

ICPC

Laceration/cut

1.6

45.6

2082

15972

D01

ICPC

Abdominal pain/cramps general

1.9

45.5

610

3364

N03AX12

ATC

[U] gabapentin; oral

1.8

45.3

767

4560

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

45.2

471

2374

A07AA11

ATC

rifaximin; oral

10.1

45.1

N05BA04

ATC

oxazepam; oral

1.7

45.1

1160

7753

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.3

45.0

170

522

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

44.9

525

2760

A02BC01

ATC

omeprazole; systemic

1.7

44.9

1139

7583

J01AA02

ATC

doxycycline; systemic

1.7

44.8

3491

30246

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

44.7

1338

9285

N06AB10

ATC

escitalopram; oral

1.7

44.7

999

6429

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

44.4

642

3629

E0000UV, ,

ATC

1.6

44.4

1862

13985

N05AX12

ATC

aripiprazole; systemic

2.7

44.2

251

970

A02BC03

ATC

lansoprazole; oral

1.6

44.1

1233

8410

K02.1

ICD-10 Finland

Caries of dentine

1.6

43.7

2780

22873

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

43.1

822

5054

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

42.9

1366

9606

WX780

NOMESCO Finland

Remote monitoring CPAP

2.5

42.6

292

1235

B01AB05

ATC

enoxaparin; parenteral

1.6

42.5

1310

9134

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.5

42.5

276

1139

K70.1

ICD-10 Finland

Alcoholic hepatitis

7.6

42.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

42.4

716

4246

R52.9

ICD-10 Finland

Pain, unspecified

2.0

42.3

518

2767

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

42.3

630

3593

M79.7

ICD-10 Finland

Fibromyalgia

2.8

42.2

218

802

R06AE07

ATC

cetirizine; oral

1.5

42.0

2014

15521

M25.5

ICD-10 Finland

Pain in joint

1.6

42.0

1611

11817

P01AB01

ATC

metronidazole; oral, rectal

1.5

41.9

1791

13454

N05CF01

ATC

zopiclone; oral

1.6

41.8

1347

9488

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

41.8

1109

7449

AA1AD

NOMESCO Finland

CT of head and brain

1.6

41.7

1164

7916

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

11.4

41.3

CL2S4, ,

SPAT

3.4

41.2

154

470

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

41.2

775

4742

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

40.8

2397

19249

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

40.5

2013

15589

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

40.4

365

1739

WX290

NOMESCO Finland

Other blockage of nerve

1.5

40.0

2282

18177

N03AX09

ATC

lamotrigine; oral

2.4

40.0

277

1177

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

39.8

196

703

N02BE01

ATC

paracetamol; systemic, rectal

1.9

39.7

3999

36321

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

39.5

632

3679

S97

ICPC

Chronic ulcer skin

2.4

39.3

273

1161

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

39.2

312

1410

N06AB03

ATC

fluoxetine; oral

1.9

38.9

581

3309

C10AB05

ATC

fenofibrate; oral

3.7

38.9

123

336

C10AX09

ATC

ezetimibe; oral

1.7

38.9

779

4844

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.8

38.8

120

323

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

38.8

438

2270

D02

ICPC

Abdominal pain epigastric

2.2

38.6

326

1510

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

9.9

38.3

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

38.2

733

4502

SFA30

NOMESCO Finland

Three-surface restoration

1.5

38.1

2008

15679

A10BH02

ATC

vildagliptin; oral

4.3

38.0

235

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.9

38.0

113

296

R51.80

ICD-10 Finland

Headache

1.7

37.9

754

4677

T83

ICPC

Overweight

3.2

37.4

147

463

R60.0

ICD-10 Finland

Localized oedema

1.9

37.2

549

3114

P03

ICPC

Feeling depressed

1.9

37.1

501

2760

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

4.4

36.9

215

R53

ICD-10 Finland

Malaise and fatigue

1.6

36.9

1081

7405

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

36.8

1118

7722

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.0

36.8

455

2433

J01FA06

ATC

roxithromycin; oral

1.5

36.7

1716

13036

D11

ICPC

Diarrhoea

1.8

36.7

581

3367

P76

ICPC

Depressive disorder

2.1

36.5

359

1766

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

36.5

1296

9278

C09DA01

ATC

losartan and diuretics; oral

1.9

36.5

474

2578

WX892

NOMESCO Finland

Monitored bed care

2.2

36.4

339

1633

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

36.4

1182

8292

M03BX02

ATC

tizanidine; oral

1.5

36.2

2885

24395

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

8.6

36.1

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

36.1

883

5781

L04AB04

ATC

adalimumab; parenteral

3.0

36.0

159

536

A06AD11

ATC

lactulose; oral

1.9

36.0

538

3062

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.5

35.9

199

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

35.8

265

1159

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

35.8

3316

28908

J20

ICD-10 Finland

Acute bronchitis

1.9

35.8

502

2799

C03AA03

ATC

hydrochlorothiazide; oral

2.1

35.8

347

1698

M01AH05

ATC

etoricoxib; oral

1.5

35.7

2921

24794

R01AD09

ATC

mometasone; nasal

1.5

35.6

2083

16530

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.1

35.6

350

1722

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.8

35.4

180

656

SFA20

NOMESCO Finland

Two-surface restoration

1.5

35.2

2736

22946

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

35.2

1526

11386

A01

ICPC

Pain general/multiple sites

1.9

35.2

481

2659

J01DA01

ATC

[U] cefalexin

1.5

35.1

2664

22230

K29.7

ICD-10 Finland

Gastritis, unspecified

2.8

35.1

184

682

UJF92

NOMESCO Finland

Capsular endoscopy

3.3

35.0

136

425

D05AX52

ATC

calcipotriol, combinations; topical

2.3

34.9

281

1275

L28

ICPC

Limited function/disability (L)

1.7

34.9

723

4527

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.0

34.8

154

520

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

34.6

184

687

K92.1

ICD-10 Finland

Melaena

2.5

34.6

229

953

K75.4

ICD-10 Finland

Autoimmune hepatitis

11.3

34.5

C09CA06

ATC

candesartan; oral

1.6

34.4

1110

7757

A97

ICPC

No disease

1.6

34.3

883

5845

N06AX12

ATC

bupropion; oral

2.0

34.3

391

2030

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

34.2

860

5662

K30

ICD-10 Finland

Functional dyspepsia

1.8

34.1

550

3201

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

34.0

1054

7296

K51.5

ICD-10 Finland

Left sided colitis

2.8

33.8

169

611

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

33.7

624

3782

C09AA05

ATC

ramipril; oral

1.6

33.7

911

6103

WX723

NOMESCO Finland

CPAP therapy

2.3

33.6

262

1172

K50.8

ICD-10 Finland

Other Crohn disease

3.6

33.5

109

304

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

33.5

496

2812

S29

ICPC

Skin symptom/complaint other

1.6

33.4

898

6004

A10AE06

ATC

insulin degludec; parenteral

2.6

33.3

199

788

R05

ICPC

Cough

1.6

33.3

1102

7737

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

33.3

510

2922

A08

ICPC

Swelling

2.3

33.1

258

1154

N30.0

ICD-10 Finland

Acute cystitis

1.7

33.1

706

4448

M01AE02

ATC

naproxen; oral, rectal

1.5

32.8

2509

20841

N06AX03

ATC

mianserin; oral

2.4

32.7

233

1002

R06.5

ICD-10 Finland

Mouth breathing

1.9

32.6

460

2566

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

32.6

2363

19417

ZY010

NOMESCO Finland

Hospital outpatient

2.3

32.6

271

1246

SPAT1263

SPAT

Sampling

1.5

32.6

1671

12850

L03

ICPC

Low back symptom/complaint

1.5

32.5

1325

9722

Z01.7

ICD-10 Finland

Laboratory examination

1.7

32.4

775

5030

M10

ICD-10 Finland

Gout

2.5

32.2

207

849

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.4

32.1

238

1042

WX722

NOMESCO Finland

PEEP

2.4

32.0

224

956

C07AG02

ATC

carvedilol; oral

2.4

32.0

235

1025

D07AD01

ATC

clobetasol; topical

1.7

32.0

765

4964

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.6

31.7

103

287

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

31.7

664

4161

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

31.6

510

2967

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

31.5

619

3810

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

31.5

1222

8866

D07XC01

ATC

betamethasone; topical

1.8

31.4

537

3176

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

31.4

2093

16882

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.3

31.3

122

382

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

31.3

955

6568

OAB72, ,

SPAT

3.5

31.3

109

318

L01BB02

ATC

mercaptopurine; oral

4.1

31.3

217

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

31.1

822

5463

R03BA02

ATC

budesonide; inhalant

1.6

31.1

787

5175

A99

ICPC

Disease/condition unspecnature/site

1.8

31.1

468

2664

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

30.8

1069

7566

D07AC13

ATC

mometasone; topical

1.5

30.7

1247

9124

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.5

30.7

105

303

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.8

30.6

153

553

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

30.6

1251

9164

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

30.6

604

3721

A02BA02

ATC

ranitidine; systemic

1.6

30.6

746

4859

J01FA10

ATC

azithromycin; systemic

1.4

30.5

2596

21863

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

10.7

30.4

A91

ICPC

Abnormal result investigation NOS

2.2

30.3

264

1237

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

30.3

385

2074

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.8

30.2

150

540

R07.3

ICD-10 Finland

Other chest pain

1.8

30.2

474

2732

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

30.2

865

5857

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

30.1

396

2157

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

30.0

1621

12536

J01FA09

ATC

clarithromycin; systemic

1.5

30.0

1397

10500

Z2446

NOMESCO Finland

Social worker

2.1

29.9

301

1492

N06AA09

ATC

amitriptyline; systemic

1.9

29.8

407

2244

Z01.2

ICD-10 Finland

Dental examination

1.4

29.7

2114

17197

L04AC05

ATC

ustekinumab; parenteral

6.1

29.7

R03AC03

ATC

terbutaline; inhalant

1.7

29.7

609

3790

R03BA05

ATC

fluticasone; inhalant

1.6

29.7

783

5197

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

29.5

329

1693

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

29.5

458

2630

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

29.5

194

805

C09BA02

ATC

enalapril and diuretics; systemic

2.1

29.4

292

1440

Z94.4

ICD-10 Finland

Liver transplant status

7.5

28.8

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

28.7

1480

11321

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

28.7

495

2933

R50.9

ICD-10 Finland

Fever, unspecified

1.7

28.7

649

4143

JN1AE, ,

SPAT

2.3

28.6

230

1043

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

28.5

482

2838

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

28.5

1230

9087

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.5

28.4

185

764

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

28.3

975

6872

JJC00

NOMESCO Finland

Allogenic transplantation of liver

9.3

28.3

SFA10

NOMESCO Finland

One-surface restoration

1.4

28.2

2487

20935

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

27.9

423

2410

C07AB02

ATC

metoprolol; systemic

1.6

27.9

660

4258

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

27.9

235

1086

A10BX09

ATC

[U] dapagliflozin

4.7

27.8

138

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

27.7

308

1583

K92.0

ICD-10 Finland

Haematemesis

3.2

27.7

111

354

E66.0

ICD-10 Finland

Obesity due to excess calories

4.4

27.5

155

A28

ICPC

Limited function/disability NOS

1.7

27.5

584

3663

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

27.5

434

2503

D06

ICPC

Abdominal pain localized other

1.9

27.4

395

2216

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

27.3

369

2026

M02AA07

ATC

piroxicam; topical

1.4

27.2

1410

10773

J02AC01

ATC

fluconazole; systemic

1.4

27.2

1681

13264

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

27.2

258

1250

L15

ICPC

Knee symptom/complaint

1.5

27.1

1098

7995

N05CD07

ATC

temazepam; oral

1.8

27.0

404

2293

R01AD08

ATC

fluticasone; nasal

1.5

26.9

1276

9580

A10BX04

ATC

[U] exenatide

4.2

26.9

175

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

26.8

846

5839

EBA00

NOMESCO Finland

Extraction of tooth

1.4

26.7

1585

12403

R74

ICPC

Upper respiratory infection acute

1.4

26.6

1500

11629

R5110, ,

SPAT

1.9

26.6

354

1935

R42

ICD-10 Finland

Dizziness and giddiness

1.5

26.5

894

6259

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

26.5

1217

9079

L08

ICPC

Shoulder symptom/complaint

1.5

26.4

1024

7382

K04.08

ICD-10 Finland

Other specified pulpit

1.8

26.4

398

2262

E87.6

ICD-10 Finland

Hypokalaemia

2.5

26.4

164

662

R05

ICD-10 Finland

Cough

1.5

26.4

929

6563

M01AB05

ATC

diclofenac; systemic, rectal

1.4

26.4

2925

25486

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.6

26.3

136

SGA01

NOMESCO Finland

Emergency treatment

1.6

26.3

789

5381

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

5.0

26.3

113

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.1

26.1

108

351

S10

ICPC

Boil/carbuncle

2.0

26.1

287

1469

P74

ICPC

Anxiety disorder/anxiety state

2.2

26.0

225

1051

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.1

25.9

171

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

25.9

309

1627

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.8

25.9

129

466

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

25.8

442

2609

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.8

25.8

128

461

A10BJ01

ATC

exenatide; parenteral

4.1

25.8

176

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

25.8

379

2137

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.6

25.7

151

593

EB1AA, ,

SPAT

1.9

25.6

322

1726

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

25.6

349

1922

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

25.5

513

3167

H01

ICPC

Ear pain/earache

1.7

25.5

531

3309

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

2.8

25.5

133

492

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.4

25.5

170

710

A04

ICPC

Weakness/tiredness general

1.6

25.5

627

4079

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.7

25.4

142

545

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.4

25.3

262

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

25.2

463

2788

N02BF02

ATC

pregabalin; oral

1.9

25.2

332

1808

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

25.2

412

2400

L12

ICPC

Hand/finger symptom/complaint

1.6

25.0

771

5287

L04AX03

ATC

methotrexate; systemic

1.7

25.0

453

2719

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

24.9

331

1807

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.6

24.9

147

579

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.5

24.9

152

609

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

24.9

569

3633

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.5

24.9

156

633

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.4

24.9

176

755

K07

ICPC

Swollen ankles/oedema

2.3

24.8

182

793

H02AB04

ATC

methylprednisolone; systemic

1.6

24.7

595

3847

UJD02

NOMESCO Finland

Gastroscopy

2.2

24.7

201

916

L16

ICPC

Ankle symptom/complaint

1.7

24.6

544

3442

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.5

24.6

159

654

I11

ICD-10 Finland

Hypertensive heart disease

7.2

24.6

S21

ICPC

Skin texture symptom/complaint

1.6

24.4

627

4118

N06AX26

ATC

vortioxetine; oral

1.8

24.4

360

2033

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

24.3

399

2326

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.4

24.3

164

689

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

24.2

1876

15296

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.0

24.2

105

351

SPAT1240

SPAT

Therapeutic discussion

1.7

24.2

453

2741

A11

ICPC

Chest pain NOS

1.8

24.2

367

2089

K04.09

ICD-10 Finland

Pulpit UNS

2.1

24.1

238

1170

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

24.1

1075

7950

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

24.1

2958

26003

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.9

24.0

181

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.4

23.9

171

737

XF402

NOMESCO Finland

ECG with work load test

1.8

23.8

405

2387

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

23.7

458

2795

D13.4

ICD-10 Finland

Benign neoplasm: Liver

5.3

23.7

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.5

23.7

152

624

K83.0

ICD-10 Finland

Cholangitis

3.6

23.6

211

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

3.3

23.6

269

XG466

NOMESCO Finland

Sleep oxymetry

2.5

23.5

145

584

N17

ICPC

Vertigo/dizziness

1.7

23.4

497

3110

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

23.4

321

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

23.4

363

2080

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

5.5

23.3

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

23.3

414

2469

ZXD05

NOMESCO Finland

Urgent procedure

1.4

23.3

1154

8695

L05

ICPC

Flank/axilla symptom/complaint

1.9

23.2

283

1501

M01AH01

ATC

celecoxib; oral

1.5

23.2

720

4937

J01CF05

ATC

flucloxacillin; systemic

1.9

23.2

325

1805

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

23.1

210

1000

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.6

23.1

214

N02BF01

ATC

gabapentin; oral

1.7

23.0

473

2935

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

23.0

1115

8363

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

23.0

234

1164

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

22.9

773

5396

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

7.4

22.9

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

22.8

2988

26410

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

22.8

962

7028

L02

ICPC

Back symptom/complaint

1.7

22.7

475

2961

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.6

22.7

130

505

N06AB06

ATC

sertraline; oral

1.7

22.7

504

3191

K85

ICPC

Elevated blood pressure

1.6

22.6

648

4362

J01CA04

ATC

amoxicillin; systemic

1.5

22.6

3597

32867

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

22.6

753

5241

OAB74, ,

SPAT

3.7

22.5

199

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.4

22.4

129

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.0

22.4

255

1322

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.8

22.3

115

423

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

22.1

1069

8005

ZX120

NOMESCO Finland

Intravenous

1.8

22.1

378

2230

L04AB01

ATC

etanercept; parenteral

3.0

22.1

322

M48.0

ICD-10 Finland

Spinal stenosis

1.7

22.0

448

2772

P01

ICPC

Feeling anxious/nervous/tense

1.6

21.9

543

3530

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

21.9

768

5399

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

21.9

591

3922

L04AC16

ATC

guselkumab; systemic

8.5

21.9

3051, ,

Kela drug reimbursment

3.5

21.9

222

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

21.8

357

2078

F32

ICD-10 Finland

Depressive episode

2.0

21.8

249

1292

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.5

21.7

965

7112

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.5

21.6

131

523

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

21.6

889

6453

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.1

21.6

205

994

SPAT1281

SPAT

Other administrative function

1.9

21.4

304

1694

N05CF02

ATC

zolpidem; oral

1.5

21.4

747

5243

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

21.4

519

3356

M79.1

ICD-10 Finland

Myalgia

1.5

21.4

662

4529

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

21.3

302

1682

U07

ICPC

Urine symptom/complaint other

1.8

21.3

340

1965

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

21.2

1112

8443

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

21.1

330

1894

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

21.0

605

4072

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

21.0

640

4363

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

21.0

319

1816

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

20.9

327

1878

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

20.9

320

1827

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.8

20.8

103

371

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

20.8

128

515

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

20.8

566

3760

A02BA04

ATC

nizatidine; systemic

1.9

20.8

273

1484

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

20.7

542

3567

OAB42, ,

SPAT

1.6

20.7

567

3772

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

20.7

208

1030

C09CA03

ATC

valsartan; oral

1.7

20.7

363

2155

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.2

20.5

171

787

WX320

NOMESCO Finland

Spinalanesthesy

1.4

20.5

943

6982

R4120

NOMESCO Finland

Occupational therapy

1.8

20.5

291

1622

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

20.5

432

2697

SPAT1054

SPAT

Examination of peripheral nervous system

3.3

20.4

242

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

20.3

231

1196

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

20.3

880

6444

N48.1

ICD-10 Finland

Balanoposthitis

2.5

20.2

129

528

A10BX02

ATC

repaglinide; oral

3.8

20.2

167

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.9

20.0

154

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

20.0

1496

12026

C02AC05

ATC

moxonidine; oral

2.2

20.0

180

855

ZXA00

NOMESCO Finland

Right side

1.4

20.0

965

7208

C07AA05

ATC

propranolol; systemic

1.5

19.8

857

6270

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

19.8

132

552

J45

ICD-10 Finland

Asthma

1.6

19.7

448

2848

C09DA06

ATC

candesartan and diuretics; oral

1.8

19.6

317

1837

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

19.6

506

3318

WX110, ,

SPAT

1.9

19.6

265

1455

358

Kela drug reimbursment

liraglutide

5.0

19.5

K72.1

ICD-10 Finland

Chronic hepatic failure

19.4

19.5

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

19.4

252

1365

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

19.4

241

1287

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

19.4

223

1160

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

19.3

320

1868

R03BB04

ATC

tiotropium bromide; inhalant

1.7

19.3

343

2043

M01AH02

ATC

rofecoxib; oral

1.6

19.3

458

2943

R06AX22

ATC

ebastine; oral

1.5

19.3

739

5277

FM1DE, ,

SPAT

6.3

19.3

A07EA02

ATC

hydrocortisone; rectal

2.7

19.2

105

399

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

19.2

540

3612

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

19.2

443

2828

N05AN01

ATC

lithium; oral

2.5

19.1

121

494

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.9

19.1

228

1201

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

19.1

875

6466

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

19.0

441

2820

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

18.9

195

975

JAH01

NOMESCO Finland

Laparoscopy

2.0

18.9

197

989

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

18.8

400

2500

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

18.8

351

2119

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

18.8

281

1591

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

6.4

18.8

S76

ICPC

Skin infection other

1.9

18.8

232

1236

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.7

18.7

364

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.5

18.7

116

469

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

18.7

988

7485

L04AA32

ATC

apremilast; oral

6.8

18.7

C07BB07

ATC

bisoprolol and thiazides; systemic

2.3

18.6

147

662

A10BD20

ATC

metformin and empagliflozin; oral

3.0

18.6

272

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

18.6

205

1050

M10.0

ICD-10 Finland

Idiopathic gout

2.3

18.6

137

599

I50.0

ICD-10 Finland

Congestive heart failure

2.1

18.6

185

913

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.6

18.6

521

3481

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

18.5

146

657

L13

ICPC

Hip symptom/complaint

1.5

18.5

757

5474

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.0

18.5

210

1088

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

18.5

212

1102

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

18.4

371

2287

D05AX02

ATC

calcipotriol; topical

2.2

18.4

160

750

R01AD58

ATC

fluticasone, combinations; nasal

1.4

18.4

1120

8690

D07AB08

ATC

desonide; topical

1.6

18.3

428

2739

R06AX27

ATC

desloratadine; oral

1.4

18.2

1252

9899

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

18.2

482

3178

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.7

18.2

347

E87.5

ICD-10 Finland

Hyperkalaemia

3.1

18.2

239

C10AA04

ATC

fluvastatin; oral

1.8

18.2

266

1497

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.6

18.1

103

399

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

18.0

1246

9857

A03

ICPC

Fever

1.5

18.0

730

5264

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

18.0

385

2411

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

17.9

132

577

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.2

17.9

148

679

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

17.9

1652

13645

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.6

17.9

101

390

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.9

17.9

284

RD210, ,

NOMESCO Finland

2.8

17.8

317

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

17.8

428

2757

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

16.6

17.8

P29

ICPC

Psychological sympt/compl other

1.7

17.8

334

2019

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

4.4

17.8

101

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

17.7

311

1845

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

17.7

213

1125

UKC02

NOMESCO Finland

Cystoscopy

1.5

17.7

515

3468

C10AA03

ATC

pravastatin; oral

1.9

17.7

238

1304

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

17.7

146

670

A10BG02

ATC

rosiglitazone; oral

3.5

17.7

178

N05AA02

ATC

levomepromazine; systemic

2.1

17.6

173

850

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.1

17.5

161

771

ZXA10

NOMESCO Finland

Bilateral

1.5

17.5

646

4572

3055, ,

Kela drug reimbursment

3.8

17.5

137

L86

ICPC

Back syndrome with radiating pain

1.8

17.4

262

1486

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

17.4

304

1801

S02

ICPC

Pruritus

2.2

17.4

149

694

C01DA14

ATC

isosorbide mononitrate; oral

1.6

17.4

376

2360

SPAT1283

SPAT

Restricted health certificate

1.5

17.4

712

5144

N05BA12

ATC

alprazolam; oral

1.6

17.4

408

2614

R52.2

ICD-10 Finland

Other chronic pain

2.1

17.3

173

855

R03DC03

ATC

montelukast; oral

1.5

17.3

701

5051

F34.1

ICD-10 Finland

Dysthymia

2.1

17.3

172

849

R04.0

ICD-10 Finland

Epistaxis

1.8

17.2

268

1536

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.2

17.2

147

684

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

17.1

319

1924

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

17.1

148

692

K63.5

ICD-10 Finland

Polyp of colon

2.4

17.1

112

465

K04.0

ICD-10 Finland

Pulpitis

1.6

17.1

418

2704

D07AA02

ATC

hydrocortisone; topical

1.5

17.1

542

3719

L04AD01

ATC

ciclosporin; systemic

2.6

17.0

365

G44.2

ICD-10 Finland

Tension-type headache

1.5

17.0

569

3947

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

5.3

17.0

T89

ICPC

Diabetes insulin dependent

2.0

17.0

185

944

M01AX17

ATC

nimesulide; oral

1.4

17.0

891

6728

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

17.0

146

682

A23

ICPC

Risk factor NOS

1.6

16.8

416

2697

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.1

16.8

235

N05AH03

ATC

olanzapine; systemic

1.8

16.7

280

1639

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.9

16.7

262

R21

ICPC

Throat symptom/complaint

1.4

16.6

864

6510

CK2S4, ,

SPAT

2.8

16.6

307

N02AA05

ATC

oxycodone; systemic

1.5

16.6

608

4295

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.1

16.6

152

728

SPAT1211

SPAT

Application of soft bandage

1.7

16.4

311

1884

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.5

16.4

103

419

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

4.7

16.3

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

16.3

229

1273

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.0

16.3

170

855

IHZ05, ,

SPAT

2.0

16.3

186

966

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

16.2

941

7219

R4190, ,

SPAT

4.2

16.2

100

R10.0

ICD-10 Finland

Acute abdomen

2.2

16.2

141

662

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

16.2

479

3236

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

16.1

801

5986

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

16.1

613

4362

I50

ICD-10 Finland

Heart failure

2.7

16.1

307

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

6.0

16.0

ZXD35

NOMESCO Finland

Usual procedure

2.2

16.0

133

613

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

16.0

525

3626

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

16.0

447

2982

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

16.0

219

1208

JN4AD

NOMESCO Finland

Body CT examination

1.6

16.0

426

2812

SPAT1377

SPAT

Polysomnography

2.1

15.9

148

713

C08CA02

ATC

felodipine; oral

1.7

15.9

299

1809

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

15.9

481

3265

SPAT1139

SPAT

Nutrition survey

2.3

15.9

119

525

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.6

15.8

418

2752

G63.2

ICD-10 Finland

Diabetic polyneuropathy

6.4

15.8

BEF00, ,

SPAT

3.7

15.8

138

C01CA24

ATC

epinephrine; parenteral

1.7

15.7

278

1653

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

15.7

131

604

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

15.7

178

922

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

15.7

202

1092

256, ,

Kela drug reimbursment

7.2

15.7

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

15.7

336

2104

M54

ICD-10 Finland

Dorsalgia

1.5

15.6

533

3708

R01AD12

ATC

fluticasone furoate; nasal

1.3

15.6

1357

11060

XQ800

NOMESCO Finland

Prick test

1.7

15.6

313

1926

M54.8

ICD-10 Finland

Other dorsalgia

1.9

15.6

197

1058

SPAT1254

SPAT

Administration of medicine

1.5

15.6

477

3244

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

15.5

277

1651

M01AB01

ATC

indometacin; systemic, rectal

1.8

15.5

239

1366

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

15.5

1018

7962

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.8

15.4

263

E000001, ,

ATC

1.4

15.4

748

5562

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

15.4

1278

10349

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

1.8

15.4

245

1415

T45

ICPC

Metabolic, Observ/health educat/advice/diet

2.9

15.3

237

N05BA01

ATC

diazepam; systemic, rectal

1.5

15.3

491

3374

E78.11

ICD-10 Finland

Other hypertriglyceridemia

4.2

15.3

SGC40

NOMESCO Finland

Preparing and restoring tooth to enable root canal treatment

2.4

15.3

101

422

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.6

15.2

327

D19

ICPC

Teeth/gum symptom/complaint

1.3

15.2

1334

10880

F31

ICD-10 Finland

Bipolar affective disorder

3.0

15.2

222

N01

ICPC

Headache

1.5

15.2

459

3114

SPAT1255

SPAT

Intravenous administration of medicine

1.8

15.2

248

1443

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.5

15.2

375

SPAT1310

SPAT

Counselling related to known health issue

1.3

15.1

1152

9206

R00.2

ICD-10 Finland

Palpitations

1.6

15.1

334

2107

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

5.6

15.1

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

15.1

231

1319

J01DA06

ATC

[U] cefuroxime

1.5

15.1

556

3930

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.1

15.0

146

715

D09

ICPC

Nausea

1.9

15.0

187

1000

N17.8

ICD-10 Finland

Other acute renal failure

3.2

15.0

177

T92

ICPC

Gout

2.7

15.0

301

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.4

15.0

105

450

L60.0

ICD-10 Finland

Ingrowing nail

1.9

15.0

205

1130

ZXA05

NOMESCO Finland

Left side

1.4

14.9

859

6571

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.4

14.9

414

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

14.9

274

1647

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

14.9

462

3150

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

14.9

238

1375

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.0

14.9

152

759

D25

ICPC

Abdominal distension

2.5

14.8

361

L14

ICPC

Leg/thigh symptom/complaint

1.6

14.8

317

1984

N05AX08

ATC

risperidone; systemic

1.7

14.8

281

1705

IGV01

NOMESCO Finland

Psychiatric network contact

3.2

14.8

184

R51

ICD-10 Finland

Headache

1.8

14.8

233

1342

N04BC05

ATC

pramipexole; oral

1.7

14.7

283

1722

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

14.7

271

1630

SGC10

NOMESCO Finland

Pulp capping

1.6

14.7

378

2473

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.6

14.7

397

2627

N06AA12

ATC

doxepin; systemic

1.9

14.7

188

1015

R29

ICPC

Respiratory symptom/complaint other

1.7

14.7

283

1724

B01AB04

ATC

dalteparin; parenteral

1.9

14.6

186

1002

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.2

14.6

117

532

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

14.5

150

752

R06.2

ICD-10 Finland

Wheezing

1.9

14.5

180

962

SPAT1104

SPAT

Monitoring of emergency patient

1.8

14.5

231

1335

R06AX13

ATC

loratadine; oral

1.4

14.4

608

4404

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

4.1

14.4

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

14.4

893

6910

K80.8

ICD-10 Finland

Other cholelithiasis

2.7

14.4

296

N07BB01

ATC

disulfiram; oral

1.9

14.4

193

1058

D02AE01

ATC

carbamide; topical

1.7

14.4

245

1443

N06AX17

ATC

milnacipran; oral

3.1

14.2

188

K08.3

ICD-10 Finland

Retained dental root

1.6

14.2

310

1948

WZC00, ,

SPAT

1.4

14.2

597

4321

U02

ICPC

Urinary frequency/urgency

1.5

14.2

542

3855

R4110, ,

SPAT

1.5

14.2

531

3762

P99

ICPC

Psychological disorders other

2.0

14.1

145

725

U71

ICPC

Cystitis/urinary infection other

1.7

14.1

257

1542

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

14.1

293

1820

D10

ICPC

Vomiting

1.7

14.1

241

1421

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

14.1

138

679

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

14.0

180

972

A03FA02

ATC

cisapride; oral, rectal

1.7

14.0

245

1452

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

14.0

206

1162

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

14.0

222

1281

A08AA62

ATC

bupropion and naltrexone; systemic

3.5

14.0

140

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

13.9

1283

10510

A10AB06

ATC

insulin glulisine; parenteral

3.3

13.9

160

C10AB02

ATC

bezafibrate; oral

3.6

13.9

126

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

13.9

323

2063

R55

ICD-10 Finland

Syncope and collapse

1.6

13.8

358

2345

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.9

13.8

178

963

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

13.7

164

865

N03AG01

ATC

valproic acid; systemic, rectal

1.7

13.7

242

1438

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.3

13.7

101

443

L04AC10

ATC

secukinumab; parenteral

3.9

13.7

100

A10BX01

ATC

guar gum; oral

2.2

13.7

112

514

UJF30, ,

SPAT

3.2

13.7

162

C03BA11

ATC

indapamide; oral

2.3

13.6

419

R96

ICPC

Asthma

1.5

13.6

387

2588

L04AC18

ATC

risankizumab; parenteral

6.5

13.6

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.8

13.6

253

K86

ICPC

Hypertension uncomplicated

1.5

13.6

467

3250

R78

ICPC

Acute bronchitis/bronchiolitis

2.5

13.6

340

WZC30

NOMESCO Finland

Teaching

1.4

13.6

646

4779

D05BB02

ATC

acitretin; oral

2.3

13.6

102

451

D64.8

ICD-10 Finland

Other specified anaemias

2.7

13.5

271

T07

ICPC

Weight gain

2.5

13.5

318

EB1VA, ,

NOMESCO Finland

1.4

13.5

773

5902

W19

ICD-10 Finland

Unspecified fall

1.6

13.4

353

2320

E000003, ,

ATC

1.9

13.4

170

915

EB1SA, ,

SPAT

1.8

13.4

220

1282

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

4.2

13.4

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

13.4

302

1915

K80

ICD-10 Finland

Cholelithiasis

2.8

13.4

239

K29

ICPC

Cardiovascular sympt/complt other

2.0

13.3

143

727

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.6

13.3

302

C09CA07

ATC

telmisartan; oral

1.6

13.3

278

1729

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

13.3

299

1894

TPH00

NOMESCO Finland

Phlebotomy

4.5

13.3

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

3.4

13.3

135

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

13.3

125

606

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

13.3

427

2933

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

13.3

259

1583

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.4

13.2

375

L04AB06

ATC

golimumab; parenteral

3.3

13.2

155

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

13.2

436

3010

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.1

13.2

181

T60

ICPC

Metabolic, Result test/procedure

3.5

13.2

126

IEY01

NOMESCO Finland

Psychoeducation, individual

3.5

13.1

131

K76

ICD-10 Finland

Other diseases of liver

15.1

13.1

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.2

13.0

108

498

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

13.0

195

1106

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.8

13.0

237

C09AA04

ATC

perindopril; oral

1.9

13.0

166

897

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

12.9

129

639

M01AC06

ATC

meloxicam; systemic, rectal

1.3

12.9

1435

12020

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.6

12.9

289

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

12.9

154

813

B01AB10

ATC

tinzaparin; parenteral

1.5

12.9

416

2859

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.4

12.9

374

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.2

12.8

158

M02AA10

ATC

ketoprofen; topical

1.4

12.8

596

4389

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.4

12.8

387

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.9

12.8

195

K08.80

ICD-10 Finland

Toothache NOS

1.5

12.8

384

2599

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.6

12.8

279

SPAT1260

SPAT

Consultation of another employee

1.4

12.8

600

4428

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.9

12.8

151

795

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

12.8

123

602

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

12.7

462

3250

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

14.1

12.7

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.9

12.7

201

L20

ICPC

Joint symptom/complaint NOS

1.9

12.7

155

824

K51.8

ICD-10 Finland

Other ulcerative colitis

2.6

12.7

280

K76.7

ICD-10 Finland

Hepatorenal syndrome

9.7

12.7

A01AB09

ATC

miconazole; local oral

1.6

12.7

294

1877

N20.1

ICD-10 Finland

Calculus of ureter

2.0

12.7

141

727

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

12.6

408

2804

ACC51

NOMESCO Finland

Release of median nerve

1.6

12.6

308

1990

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

12.6

713

5426

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.4

12.6

353

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

12.6

1512

12781

Z2445

NOMESCO Finland

Psychologist

1.9

12.6

162

877

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

12.6

313

2032

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

12.6

405

2783

B01AC04

ATC

clopidogrel; oral

1.5

12.5

489

3488

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

12.5

266

1661

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.7

12.5

255

1576

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

12.5

234

1414

E03

ICD-10 Finland

Other hypothyroidism

1.7

12.5

235

1422

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

12.5

313

2035

ZXD20

NOMESCO Finland

Day surgery

1.5

12.5

477

3390

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

12.5

169

930

N06AA10

ATC

nortriptyline; systemic

2.3

12.5

417

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

12.5

215

1271

J46

ICD-10 Finland

Status asthmaticus

2.1

12.5

114

547

S80.0

ICD-10 Finland

Contusion of knee

1.6

12.4

316

2061

A05

ICPC

Feeling ill

1.7

12.4

228

1371

KH1AD

NOMESCO Finland

CT of urinary organs

1.9

12.4

143

746

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

5.6

12.4

J01DA09

ATC

[U] cefadroxil

1.3

12.4

1019

8198

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.6

12.4

278

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

12.3

218

1298

S06.0

ICD-10 Finland

Concussion

1.5

12.3

405

2794

J01EA01

ATC

trimethoprim; systemic

1.3

12.3

875

6896

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

12.3

245

1507

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

12.2

226

1362

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.4

12.2

352

SPAT1219

SPAT

Assessment of need for vocational rehabilitation

5.1

12.2

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

12.2

371

2519

K70.4

ICD-10 Finland

Alcoholic hepatic failure

4.4

12.1

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.2

12.1

423

M54.3

ICD-10 Finland

Sciatica

1.7

12.0

242

1491

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

4.1

12.0

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

12.0

187

1074

N20.9

ICD-10 Finland

Urinary calculus, unspecified

2.1

12.0

105

496

R06AE09

ATC

levocetirizine; oral

1.4

12.0

572

4232

A06AC51

ATC

ispaghula, combinations; oral

1.8

11.9

172

965

SPAT1248

SPAT

OTHER EXAMINATIONS, PROCEDURES, TREATMENT ETC.

5.0

11.9

S22.3

ICD-10 Finland

Fracture of rib

1.6

11.9

278

1777

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

11.9

414

2887

B82

ICPC

Anaemia other/unspecified

2.2

11.9

102

477

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.7

11.9

101

D82

ICPC

Teeth/gum disease

1.3

11.9

1566

13360

SPAT1312

SPAT

General health counselling

1.3

11.9

1126

9226

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.8

11.8

160

880

SPAT1097

SPAT

Recording of ECG

1.4

11.8

462

3295

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

11.8

148

794

K80

ICPC

Cardiac arrhythmia NOS

1.6

11.8

313

2061

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

11.8

457

3255

T62

ICPC

Metabolic, Administrative procedure

5.9

11.8

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

3.6

11.7

102

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

11.7

278

1784

R03BA08

ATC

ciclesonide; inhalant

1.5

11.7

339

2277

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.5

11.7

304

J01FA15

ATC

telithromycin; oral

1.5

11.7

398

2765

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

11.7

397

2757

R2110

NOMESCO Finland

Giving the first information

1.6

11.7

253

1589

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

11.7

253

1589

A07AA02

ATC

nystatin; oral

1.7

11.7

195

1143

K57

ICD-10 Finland

Diverticular disease of intestine

2.2

11.6

423

K57.1

ICD-10 Finland

Diverticular disease of small intestine without perforation or abscess

2.7

11.6

234

JF1AD

NOMESCO Finland

Small bowel CT

3.4

11.6

117

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

11.6

262

1661

H70

ICPC

Otitis externa

2.2

11.6

417

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

11.6

258

1630

L40.8

ICD-10 Finland

Other psoriasis

3.3

11.6

127

IHZ04, ,

SPAT

2.3

11.6

354

P01BA02

ATC

hydroxychloroquine; oral

1.5

11.6

313

2071

K76.6

ICD-10 Finland

Portal hypertension

19.0

11.6

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

11.6

161

894

S91

ICPC

Psoriasis

3.1

11.6

158

S22

ICPC

Nail symptom/complaint

1.6

11.6

260

1648

G03DB01

ATC

dydrogesterone; oral

1.4

11.5

475

3421

N06AX05

ATC

trazodone; oral

2.1

11.5

106

510

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

11.5

226

1385

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

11.5

1604

13766

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

3.7

11.5

A07DA03

ATC

loperamide; oral

2.1

11.4

112

552

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

11.4

146

789

F93.89

ICD-10 Finland

Other childhood emotional disorders

4.4

11.4

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.7

11.4

225

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

11.4

121

614

SDA03

NOMESCO Finland

Periodontal treatment

1.3

11.4

1738

15061

M01AB55

ATC

diclofenac, combinations; oral

1.7

11.4

217

1319

T29

ICPC

Endocr/metab/nutr sympt/compl other

2.3

11.4

351

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.4

11.4

302

IEV99

NOMESCO Finland

Other psychiatric network intervention

3.9

11.4

U13

ICPC

Bladder symptom/complaint other

2.1

11.3

107

520

N02AJ13

ATC

tramadol and paracetamol; systemic

2.2

11.3

454

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.6

11.3

249

B01AA03

ATC

warfarin; systemic

1.4

11.3

471

3401

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.6

11.2

244

R60.1

ICD-10 Finland

Generalized oedema

3.5

11.2

110

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

11.2

122

625

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.4

11.2

335

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

11.2

230

1426

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

11.2

364

2506

C09DA03

ATC

valsartan and diuretics; oral

1.8

11.2

164

926

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

11.2

221

1357

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

11.2

184

1075

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.4

11.1

317

A10AD05

ATC

insulin aspart; parenteral

2.9

11.1

183

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

11.1

289

1895

207

Kela drug reimbursment

Chronic arrhythmias

1.5

11.1

423

3002

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

11.1

469

3394

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

11.1

144

783

L04

ICPC

Chest symptom/complaint

1.6

11.1

247

1563

KGH10

NOMESCO Finland

Operation for phimosis

2.1

11.0

102

492

WVA20

NOMESCO Finland

Medicine administration

2.0

11.0

115

580

B02AA02

ATC

tranexamic acid; systemic

1.4

11.0

566

4235

C01AA05

ATC

digoxin; systemic

1.8

11.0

162

915

R03BA01

ATC

beclometasone; inhalant

1.4

11.0

499

3656

K11.70

ICD-10 Finland

Hypoptyalism

3.8

11.0

IDY02, ,

SPAT

5.7

11.0

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

11.0

271

1756

XW000

NOMESCO Finland

Bone marrow biopsy

1.9

11.0

143

778

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

11.0

445

3197

K80.4

ICD-10 Finland

Calculus of bile duct with cholecystitis

3.2

10.9

132

SPAT1010

SPAT

Ophthalmoscopy

4.6

10.9

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

10.9

328

2220

N19

ICD-10 Finland

Unspecified kidney failure

2.0

10.9

110

548

K76.80

ICD-10 Finland

Hepatic cyst

3.3

10.9

122

WX290, ,

SPAT

1.9

10.9

146

801

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

10.9

170

977

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

10.9

172

992

D12

ICPC

Constipation

1.9

10.9

127

666

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

2.7

10.9

202

K60.1

ICD-10 Finland

Chronic anal fissure

2.1

10.9

101

488

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

10.9

820

6503

JKA20

NOMESCO Finland

Cholecystectomy

2.3

10.9

377

SGB20

NOMESCO Finland

Root filling of tooth with onetwo root canals

1.6

10.8

263

1698

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

10.8

407

2882

P15

ICPC

Chronic alcohol abuse

1.9

10.8

139

753

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.1

10.8

106

523

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.0

10.8

115

585

ZY000

NOMESCO Finland

Hospital inpatient

2.6

10.8

232

SPAT1229

SPAT

Assessment of need for aid

1.6

10.7

227

1417

Z00.8

ICD-10 Finland

Other general examinations

1.5

10.7

298

1984

A10BB01

ATC

glibenclamide; oral

2.3

10.7

323

K50

ICD-10 Finland

Crohn disease [regional enteritis]

4.6

10.7

L04AC13

ATC

ixekizumab; parenteral

4.6

10.7

Z00.0

ICD-10 Finland

General medical examination

1.3

10.7

697

5413

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

10.7

3991

38219

SPAT1252

SPAT

Overall medication plan or its review

1.7

10.7

198

1195

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.9

10.7

171

N06AB05

ATC

paroxetine; oral

1.6

10.7

236

1490

A10BD03

ATC

metformin and rosiglitazone; systemic

2.7

10.6

199

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.8

10.6

F33

ICD-10 Finland

Recurrent depressive disorder

2.1

10.6

100

486

SPAT1336

SPAT

Request for examination

1.9

10.6

123

644

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.2

10.6

407

WZB00, ,

SPAT

1.5

10.6

342

2352

K05.18

ICD-10 Finland

Chronic gingivitis

1.5

10.5

303

2032

R76.0

ICD-10 Finland

Raised antibody titre

5.0

10.5

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.0

10.5

R13

ICD-10 Finland

Dysphagia

1.6

10.5

251

1615

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

10.5

337

2314

B80

ICPC

Iron deficiency anaemia

2.1

10.5

449

I84

ICD-10 Finland

Hemorrhoids

2.1

10.4

483

D01AC02

ATC

miconazole; topical

1.6

10.4

256

1658

E86

ICD-10 Finland

Volume depletion

2.2

10.4

372

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

10.3

493

3642

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

10.3

162

933

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

10.3

228

1439

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.2

10.3

360

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.7

10.3

191

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.1

10.3

425

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

10.3

789

6270

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.8

10.3

186

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.7

10.2

209

C05AA08

ATC

fluocortolone; rectal, topical

1.4

10.2

491

3632

C10AB04

ATC

gemfibrozil; oral

4.0

10.2

TQW80

NOMESCO Finland

Local dermatologic skincare

2.0

10.2

102

508

R04.2

ICD-10 Finland

Haemoptysis

2.0

10.2

111

570

B01AF02

ATC

apixaban; oral

1.4

10.2

393

2798

L04AB02

ATC

infliximab; parenteral

3.5

10.1

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

10.1

120

634

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

10.1

264

1734

SPAT1301

SPAT

No procedures

1.3

10.1

1044

8622

R12

ICD-10 Finland

Heartburn

1.5

10.1

332

2291

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.5

10.1

252

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

10.1

2138

19113

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.3

10.1

326

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.4

10.0

295

A02BX02

ATC

sucralfate; oral

1.9

10.0

124

664

UJH02

NOMESCO Finland

Anoscopy

1.8

10.0

152

868

T66

ICPC

Metabolic, Referral to non-MD provider

4.6

10.0

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

10.0

201

1240

K29.8

ICD-10 Finland

Duodenitis

3.2

10.0

124

X58

ICD-10 Finland

Exposure to other specified factors

1.4

10.0

598

4583

OAB49, ,

SPAT

3.3

10.0

114

ICB06, ,

NOMESCO Finland

3.3

10.0

114

L90

ICPC

Osteoarthrosis of knee

1.6

10.0

235

1508

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

9.9

134

738

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

4.1

9.9

J01CA08

ATC

pivmecillinam; oral

1.2

9.9

1433

12301

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

2.4

9.9

285

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.9

9.9

124

668

D75.1

ICD-10 Finland

Secondary polycythaemia

3.4

9.9

100

N05AE04

ATC

ziprasidone; systemic

3.4

9.9

100

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.8

9.8

149

850

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

9.8

347

2427

N05AE05

ATC

lurasidone; oral

4.3

9.8

R06

ICPC

Nose bleed/epistaxis

2.2

9.8

355

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.2

9.8

375

K86.2

ICD-10 Finland

Cyst of pancreas

2.8

9.8

163

WW200

NOMESCO Finland

Immunization

1.9

9.8

112

585

Z50.1

ICD-10 Finland

Other physical therapy

1.7

9.7

186

1132

KMAK, ,

NOMESCO Finland

1.2

9.7

2085

18630

SFD11

NOMESCO Finland

Gradual caries removal, at least two tooth surfaces

1.9

9.7

115

607

F33.8

ICD-10 Finland

Other recurrent depressive disorders

2.9

9.7

158

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

9.7

568

4336

IGY02, ,

SPAT

2.3

9.7

331

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

9.7

234

1509

R07

ICPC

Sneezing/nasal congestion

1.6

9.7

249

1629

QDB10, ,

SPAT

2.0

9.7

476

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

9.7

173

1034

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

9.7

939

7689

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.5

9.7

233

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.5

9.7

239

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

9.7

490

3657

N30

ICD-10 Finland

Cystitis

1.5

9.6

290

1964

UJK02

NOMESCO Finland

ERCP

2.1

9.6

410

101

Kela drug reimbursment

Anterior pituitary hypofunction

3.0

9.6

132

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

9.6

332

2312

R03AC13

ATC

formoterol; inhalant

1.7

9.6

174

1044

J01DC02

ATC

cefuroxime; systemic

1.6

9.6

210

1323

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

7.8

9.6

B60

ICPC

Blood and Immunity, Result test/procedure

3.0

9.6

143

C07AB03

ATC

atenolol; systemic

1.7

9.6

154

894

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

9.6

107

554

A29

ICPC

General symptom/complaint other

1.4

9.6

467

3463

SPAT1216

SPAT

Assessment of functional ability

1.4

9.6

437

3205

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

9.6

273

1829

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.0

9.6

472

U01

ICPC

Dysuria/painful urination

1.5

9.5

268

1789

SPAT1058

SPAT

PEF monitoring instruction

1.5

9.5

265

1765

K81.0

ICD-10 Finland

Acute cholecystitis

2.3

9.5

321

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.0

9.5

493

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

9.5

169

1009

N05AB03

ATC

perphenazine; systemic, rectal

1.8

9.5

136

763

AA40B, ,

NOMESCO Finland

3.8

9.5

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

9.5

346

2437

H81

ICPC

Excessive ear wax

1.3

9.5

585

4503

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.6

9.4

230

1487

212

Kela drug reimbursment

Gout

2.5

9.4

224

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.5

9.4

242

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.5

9.4

334

2339

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.6

9.4

233

1513

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

9.4

482

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

9.4

354

2508

A12BA01

ATC

potassium chloride; oral

2.0

9.4

455

D02AX

ATC

Other emollients and protectives

1.9

9.4

112

594

1508

Kela drug reimbursment

Lenvatinib

21.7

9.3

L01

ICPC

Neck symptom/complaint

1.3

9.3

640

5001

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

9.3

301

2069

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.3

9.3

299

C09DB01

ATC

valsartan and amlodipine; oral

1.8

9.3

132

739

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.1

9.3

383

L29

ICPC

Musculoskeletal sympt/complt other

1.5

9.3

326

2278

C09BA03

ATC

lisinopril and diuretics; oral

2.3

9.3

293

R25.2

ICD-10 Finland

Cramp and spasm

2.0

9.3

491

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

2.8

9.3

168

S17

ICPC

Abrasion/scratch/blister

2.1

9.3

377

A10BD15

ATC

metformin and dapagliflozin; oral

2.9

9.3

146

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

4.0

9.2

R73

ICD-10 Finland

Elevated blood glucose level

1.9

9.2

120

654

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

1.9

9.2

113

604

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.2

9.2

358

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

9.2

649

5090

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.1

9.2

391

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

9.2

194

1212

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

9.2

231

1505

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

2.4

9.2

239

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

3.4

9.2

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.1

9.2

412

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

9.1

521

3960

SPAT1284

SPAT

Extensive health certificate

2.0

9.1

487

J01MA14

ATC

moxifloxacin; systemic

1.5

9.1

314

2186

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.9

9.1

110

585

R94

ICD-10 Finland

Abnormal results of function studies

7.7

9.1

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.8

9.1

120

657

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.7

9.1

145

841

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

4.4

9.1

UJD10, ,

SPAT

1.9

9.1

104

544

IAB08

NOMESCO Finland

Consultation concerning a patient who has attempted suicide

4.8

9.1

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

11.5

9.1

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

2.4

9.0

259

OAB93, ,

SPAT

1.5

9.0

290

1991

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

4.0

9.0

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.1

9.0

381

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

2.5

9.0

211

WX213

NOMESCO Finland

Lower leg blockade

3.0

9.0

132

K81.9

ICD-10 Finland

Cholecystitis, unspecified

3.0

9.0

127

F32.0

ICD-10 Finland

Mild depressive episode

1.9

9.0

108

574

N91.4

ICD-10 Finland

Secondary oligomenorrhoea

4.1

9.0

R31

ICD-10 Finland

Unspecified haematuria

1.5

9.0

299

2069

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

3.8

8.9

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.6

8.9

199

1260

K85.8

ICD-10 Finland

Other acute pancreatitis

3.1

8.9

117

3019

Kela drug reimbursment

Lenvatinib

18.6

8.9

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

8.9

209

1340

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.1

8.9

390

M07.3

ICD-10 Finland

Other psoriatic arthropathies

2.6

8.9

195

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.1

8.9

397

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.6

8.9

206

1318

Z72.0

ICD-10 Finland

Tobacco use

1.9

8.8

106

563

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

8.8

113

613

-50

ICPC

Medication/prescr/renewal

1.8

8.8

131

744

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

4.5

8.8

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.7

8.8

152

901

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

8.8

133

759

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

2.0

8.8

425

L73.2

ICD-10 Finland

Hidradenitis suppurativa

2.6

8.8

190

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.9

8.8

112

607

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

8.8

270

1838

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.8

8.8

145

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

8.8

258

1740

C02EA02, ,

ATC

2.0

8.8

460

C08CA05

ATC

nifedipine; systemic

1.7

8.8

165

1002

D06AX01

ATC

fusidic acid; topical

1.5

8.7

320

2255

S94

ICPC

Ingrowing nail

2.2

8.7

314

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

8.7

184

1150

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.3

8.7

289

A01AB04

ATC

amphotericin B; local oral

1.8

8.7

137

792

UDC00

NOMESCO Finland

Ear microscopy

1.5

8.7

253

1703

B37.2

ICD-10 Finland

Candidiasis of skin and nail

2.9

8.7

135

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.2

8.7

315

A02BA03

ATC

famotidine; systemic

1.9

8.7

107

574

K03.66

ICD-10 Finland

Tooth plaque

1.5

8.7

295

2050

K02.2

ICD-10 Finland

Caries of cementum

1.7

8.7

165

1005

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

8.7

392

2870

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.1

8.6

348

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

8.6

368

2667

XKD00

NOMESCO Finland

Uroflowmetry

1.4

8.6

421

3122

N05AF01

ATC

flupentixol; systemic

2.3

8.6

265

B99

ICPC

Blood/lymph/spleen disease other

4.0

8.6

G83.4

ICD-10 Finland

Cauda equina syndrome

4.0

8.6

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

8.6

145

855

M01AC01

ATC

piroxicam; systemic, rectal

1.4

8.6

442

3307

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

8.6

209

1353

198

Kela drug reimbursment

Sorafenib

8.2

8.6

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

11.6

8.6

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

8.5

389

2851

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.4

8.5

229

A02BC04

ATC

rabeprazole; oral

1.4

8.5

338

2417

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

8.5

111

606

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.0

8.5

486

DHB50

NOMESCO Finland

Turbinoplasty

1.9

8.5

107

578

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.8

8.5

148

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

8.5

132

761

N06AG02

ATC

moclobemide; oral

1.7

8.5

151

904

D05AX03

ATC

calcitriol; topical

2.4

8.5

224

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.2

8.4

312

R09

ICPC

Sinus symptom/complaint

1.5

8.4

308

2169

ECB00

NOMESCO Finland

Suture of gingiva

1.7

8.4

135

784

104

Kela drug reimbursment

Thyroid insufficiency

1.5

8.4

235

1567

M54.2

ICD-10 Finland

Cervicalgia

1.4

8.4

317

2245

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.0

8.4

412

F40.1

ICD-10 Finland

Social phobias

1.9

8.4

102

544

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

8.4

221

1455

Z13.6

ICD-10 Finland

Special screening examination for cardiovascular disorders

3.0

8.4

116

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.9

8.4

108

587

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.8

8.4

120

674

F61

ICD-10 Finland

Mixed and other personality disorders

3.9

8.4

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

8.4

183

1154

K86.1

ICD-10 Finland

Other chronic pancreatitis

2.9

8.4

127

-1, ,

NOMESCO Finland

1.2

8.4

1291

11115

SPAT1342

SPAT

Referral to specialised care

2.6

8.3

172

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

8.3

528

4077

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

2.7

8.3

155

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

2.6

8.3

178

J01FA01

ATC

erythromycin; systemic

1.3

8.3

494

3779

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

8.5

8.3

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

10.7

8.3

L04AA06

ATC

mycophenolic acid; systemic

2.0

8.3

408

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.0

8.3

415

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

8.2

153

926

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

8.2

255

1739

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

8.2

163

1004

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

2.5

8.2

197

F01

ICPC

Eye pain

1.8

8.2

115

643

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.8

8.2

121

687

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

8.2

201

1304

T99

ICPC

Endocr/metab/nutrit disease other

2.2

8.2

297

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.2

8.2

310

A08AA02

ATC

fenfluramine; oral

2.8

8.2

140

TGC00

NOMESCO Finland

Bronchial lavation

2.0

8.1

445

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

8.1

143

854

L50.0

ICD-10 Finland

Allergic urticaria

1.9

8.1

100

537

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

8.1

139

824

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.0

8.1

398

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

8.1

415

3104

A02BDXX, ,

ATC

1.8

8.1

106

581

T30

ICPC

Metabolic, Medical examin/health eval complete

4.0

8.1

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

2.8

8.0

141

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.9

8.0

468

EBA00, ,

SPAT

1.9

8.0

102

553

IGP01

NOMESCO Finland

Psychiatric family contact

3.0

8.0

114

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.1

8.0

319

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

8.0

387

2866

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.0

8.0

441

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.7

8.0

135

797

S01

ICPC

Pain/tenderness of skin

1.6

8.0

165

1027

H02AB09

ATC

hydrocortisone; systemic

1.9

8.0

469

N05AF03

ATC

chlorprothixene; systemic

1.9

8.0

526

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

7.9

122

701

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

7.9

218

1450

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.2

7.9

301

A77

ICPC

Viral disease other/NOS

1.7

7.9

125

724

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

7.9

197

1283

AA400

NOMESCO Finland

Electroconvulsive therapy

2.9

7.9

126

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.0

7.9

395

N03AE01

ATC

clonazepam; systemic

1.6

7.9

202

1324

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.7

7.9

147

892

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

7.8

791

6491

OAB43, ,

SPAT

0.8

7.8

1031

12076

C09DA07

ATC

telmisartan and diuretics; oral

1.7

7.8

146

885

TJK01

NOMESCO Finland

Laparoscopic cholangiography

2.8

7.8

132

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.4

7.8

413

3101

R35

ICD-10 Finland

Polyuria

1.5

7.8

216

1439

UJF32, ,

SPAT

1.7

7.8

133

787

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

7.8

101

551

SPAT1094

SPAT

Continuous Positive Airway Pressure

2.5

7.8

184

K83.1

ICD-10 Finland

Obstruction of bile duct

2.4

7.8

202

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.2

7.8

271

R52.0

ICD-10 Finland

Acute pain

1.7

7.8

125

728

QXB99, ,

SPAT

1.9

7.8

100

545

R83

ICPC

Respiratory infection other

1.2

7.7

1036

8775

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

2.4

7.7

215

A08AB01

ATC

orlistat; oral

3.0

7.7

106

K29.6

ICD-10 Finland

Other gastritis

2.5

7.7

185

R03AK11

ATC

formoterol and fluticasone; inhalant

1.9

7.7

503

N07BA03

ATC

varenicline; oral

1.5

7.7

198

1298

5718X

ICD-9 Finland

Chronic liver disease and cirrhosis, Other chronic nonalcoholic liver disease

45.1

7.7

K70

ICD-10 Finland

Alcoholic liver disease

15.0

7.7

L01EX08

ATC

lenvatinib; oral

15.0

7.7

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.7

7.7

132

783

R07.0

ICD-10 Finland

Pain in throat

1.5

7.7

270

1889

X72

ICPC

Genital candidiasis female

2.6

7.7

162

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.4

7.7

216

F29

ICPC

Eye symptom/complaint other

1.4

7.7

385

2869

SPAT1285

SPAT

Provision of consultation response

1.6

7.6

163

1023

JF1BD

NOMESCO Finland

Very extensive small bowel CT

3.3

7.6

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

2.2

7.6

293

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

2.3

7.6

223

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

18.4

7.6

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

7.6

345

2529

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

2.9

7.6

118

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

2.8

7.6

129

N02AC04

ATC

dextropropoxyphene; oral

1.9

7.6

478

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.2

7.5

294

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

7.5

347

2548

R03AC12

ATC

salmeterol; inhalant

1.7

7.5

126

742

288

Kela drug reimbursment

Febuxostat

4.1

7.5

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

7.5

409

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

1.9

7.5

465

I81

ICD-10 Finland

Portal vein thrombosis

3.8

7.5

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.6

7.5

167

1059

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

2.6

7.5

158

S20

ICPC

Corn/callosity

2.1

7.5

348

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

7.5

112

639

TK800

NOMESCO Finland

Hemodialysis

2.0

7.5

389

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.4

7.5

200

IBA01, ,

SPAT

2.0

7.5

396

M54.1

ICD-10 Finland

Radiculopathy

1.6

7.5

152

943

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.5

7.5

225

1527

J01

ICD-10 Finland

Acute sinusitis

1.5

7.5

218

1470

L04AA13

ATC

[U] leflunomide

1.9

7.5

509

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

2.0

7.5

376

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.1

7.4

309

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

7.4

435

3319

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

3.1

7.4

A10AD04

ATC

insulin lispro; parenteral

4.4

7.4

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.5

7.4

233

1595

R74

ICD-10 Finland

Abnormal serum enzyme levels

3.5

7.4

N62

ICD-10 Finland

Hypertrophy of breast

1.6

7.4

154

961

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.1

7.4

337

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

7.4

362

2688

N20.0

ICD-10 Finland

Calculus of kidney

2.0

7.3

378

M70.7

ICD-10 Finland

Other bursitis of hip

1.9

7.3

490

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

7.3

204

1362

XF404

NOMESCO Finland

Ambulatory ECG

1.4

7.3

266

1874

F10.24

ICD-10 Finland

Alcohol depence active use

2.1

7.3

318

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

3.0

7.3

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.6

7.3

182

1186

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.0

7.3

407

K05.38

ICD-10 Finland

Other chronic periodontitis

1.8

7.3

109

623

K03.28

ICD-10 Finland

Other erosion of teeth

1.8

7.3

100

557

D94

ICPC

Chronic enteritis/ulcerative colitis

2.8

7.3

121

L01BA01

ATC

methotrexate; systemic

1.7

7.3

125

743

K85

ICD-10 Finland

Acute pancreatitis

2.3

7.2

241

PC2SC

NOMESCO Finland

Liver angiography with X-ray

15.8

7.2

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

7.2

1423

12513

J01MA06

ATC

norfloxacin; oral

1.3

7.2

415

3160

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

7.2

297

2142

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.2

7.2

242

F32.8

ICD-10 Finland

Other depressive episodes

2.1

7.2

334

F50.8

ICD-10 Finland

Other eating disorders

3.9

7.2

3005

Kela drug reimbursment

Tofacitinib

3.9

7.2

K07.60

ICD-10 Finland

Snapping jaw

1.5

7.1

188

1240

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

3.6

7.1

M01AX01

ATC

nabumetone; oral

1.7

7.1

135

823

P25

ICPC

Phase of life problem adult

1.6

7.1

158

1002

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

7.1

409

3112

L30.4

ICD-10 Finland

Erythema intertrigo

2.2

7.1

262

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.3

7.1

230

L65.9

ICD-10 Finland

Nonscarring hair loss, unspecified

3.4

7.1

R68.2

ICD-10 Finland

Dry mouth, unspecified

2.9

7.1

106

A08.5

ICD-10 Finland

Other specified intestinal infections

2.9

7.1

106

L68.0

ICD-10 Finland

Hirsutism

3.3

7.1

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.6

7.1

153

964

A10AB04

ATC

insulin lispro; parenteral

1.7

7.1

112

650

L40

ICD-10 Finland

Psoriasis

1.9

7.1

418

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.7

7.1

134

817

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.7

7.0

140

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

8.8

7.0

D73.1

ICD-10 Finland

Hypersplenism

10.0

7.0

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.3

7.0

395

2996

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.3

7.0

225

XLA10, ,

NOMESCO Finland

1.6

7.0

173

1125

ZXH06, ,

SPAT

1.6

7.0

176

1149

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.1

7.0

290

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.7

7.0

111

645

K59.0

ICD-10 Finland

Constipation

1.6

7.0

165

1062

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

7.0

133

812

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

7.0

332

2453

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

7.0

449

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.3

7.0

226

T31

ICPC

Metabolic, Medical examin/health eval partial

2.8

6.9

124

K61.0

ICD-10 Finland

Anal abscess

2.0

6.9

338

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.4

6.9

195

L11

ICPC

Wrist symptom/complaint

1.4

6.9

343

2550

N03AX11

ATC

topiramate; oral

1.8

6.9

507

C07AB05

ATC

betaxolol; oral

2.1

6.9

318

SDA05

NOMESCO Finland

Very demanding periodontal treatment

1.4

6.9

284

2046

H3600, E113,

ICD-10 Finland

2.7

6.9

130

B27.9

ICD-10 Finland

Infectious mononucleosis, unspecified

3.7

6.9

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.7

6.9

119

708

A92

ICPC

Allergy/allergic reaction NOS

1.7

6.9

115

678

Z29.9

ICD-10 Finland

Prophylactic measure, unspecified

2.7

6.9

136

JN3AE, ,

SPAT

1.6

6.9

163

1051

K51

ICD-10 Finland

Ulcerative colitis

2.4

6.9

196

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.1

6.8

306

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.3

6.8

436

3369

SXC05

NOMESCO Finland

Other oral or dental procedure

1.5

6.8

242

1697

A13

ICPC

Concern/fear medical treatment

2.0

6.8

368

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.8

6.8

510

H29

ICPC

Ear symptom/complaint other

1.3

6.8

419

3222

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.4

6.8

185

N06AX18

ATC

reboxetine; oral

2.3

6.7

210

G93.4

ICD-10 Finland

Encephalopathy, unspecified

5.6

6.7

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

6.7

248

1752

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.7

6.7

119

713

L84

ICD-10 Finland

Corns and callosities

1.7

6.7

115

683

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.7

6.7

105

608

WZC30, ,

SPAT

1.4

6.7

303

2219

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

1.9

6.7

419

L18

ICPC

Muscle pain

1.6

6.7

149

946

R25.1

ICD-10 Finland

Tremor, unspecified

1.8

6.7

101

579

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

2.3

6.7

211

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.2

6.7

256

D03

ICPC

Heartburn

1.6

6.7

139

869

R99

ICPC

Respiratory disease other

2.0

6.7

357

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

2.7

6.7

127

K05.08

ICD-10 Finland

Another acute gingivitis

1.7

6.6

118

708

RK320, ,

NOMESCO Finland

3.0

6.6

J01DA08

ATC

[U] cefaclor

1.3

6.6

370

2803

SAA04

NOMESCO Finland

Special examination of mouth

1.5

6.6

178

1180

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.2

6.6

884

7471

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

6.6

566

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.3

6.6

212

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.7

6.6

127

778

L99

ICPC

Musculoskeletal disease other

1.9

6.6

457

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

2.1

6.6

277

L09

ICPC

Arm symptom/complaint

1.5

6.6

180

1198

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

2.4

6.6

175

JN4CD

NOMESCO Finland

Very extensive body CT

1.7

6.6

108

634

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.5

6.6

167

1094

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.9

6.6

408

57408

ICD-8 Finland

Cholelithiasis, Alia definita

2.9

6.6

100

I95.9

ICD-10 Finland

Hypotension, unspecified

2.3

6.6

219

K11.2

ICD-10 Finland

Sialoadenitis

1.7

6.6

117

703

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.5

6.6

207

1420

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.3

6.6

194

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.5

6.5

199

1355

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

6.5

1092

9438

IEZ99

NOMESCO Finland

Other psychiatric rehabilitation intervention

3.8

6.5

L04AA29

ATC

[U] tofacitinib

3.8

6.5

L43.8

ICD-10 Finland

Other lichen planus

2.0

6.5

312

D98

ICPC

Cholecystitis/cholelithiasis

2.8

6.5

106

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

6.5

432

3358

OAB76, ,

SPAT

2.1

6.5

299

R19.4

ICD-10 Finland

Change in bowel habit

1.7

6.5

102

592

N05BE01

ATC

buspirone; oral

1.7

6.5

106

622

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

6.5

168

1106

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.3

6.5

411

3174

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.4

6.5

255

1825

SPAT1227

SPAT

Substance abuse rehabilitation

2.9

6.5

101

S04

ICPC

Lump/swelling localized

1.3

6.4

387

2965

E78.2

ICD-10 Finland

Mixed hyperlipidaemia

5.7

6.4

K86.8

ICD-10 Finland

Other specified diseases of pancreas

3.9

6.4

WX882

NOMESCO Finland

High dependency care

1.8

6.4

483

XX9TE

NOMESCO Finland

Compementary ultrasound examination

2.7

6.4

118

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

6.4

214

1484

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.6

6.4

147

941

H60.3

ICD-10 Finland

Other infective otitis externa

1.8

6.4

498

A10BB07

ATC

glipizide; oral

3.3

6.4

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

6.4

131

816

R03DA04

ATC

theophylline; systemic, rectal

1.7

6.4

120

731

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.8

6.4

565

Y6099

ICD-8 Finland

Prenatal care and observation

1.6

6.4

151

974

SPA47

NOMESCO Finland

Precision impression for denture

1.8

6.4

558

E14

ICD-10 Finland

Unspecified diabetes mellitus

3.7

6.4

H53.2

ICD-10 Finland

Diplopia

1.7

6.4

110

656

F73

ICPC

Eye infection/inflammation other

1.9

6.4

420

D50

ICD-10 Finland

Iron deficiency anaemia

1.9

6.3

413

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

4.1

6.3

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

2.4

6.3

166

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.8

6.3

544

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

8.1

6.3

TAB00

NOMESCO Finland

Lumbar puncture

1.5

6.3

159

1040

H36.01

ICD-10 Finland

Diabetic maculopathy

2.3

6.3

210

L88

ICPC

Rheumatoid/seropositive arthritis

1.6

6.3

144

921

S22

ICD-10 Finland

Fracture of rib(s), sternum and thoracic spine

5.2

6.3

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

3.6

6.3

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

2.9

6.3

R51.81

ICD-10 Finland

Facial pain NOS

1.8

6.3

501

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

5.9

6.3

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

6.3

228

1607

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.6

6.3

132

828

E73.9

ICD-10 Finland

Lactose intolerance, unspecified

3.3

6.3

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.6

6.3

129

805

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.8

6.3

451

E000002, ,

ATC

1.3

6.3

364

2776

D91

ICPC

Abdominal hernia other

2.2

6.3

211

6488A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance

2.0

6.2

290

EB1HA, ,

SPAT

1.7

6.2

554

-60

ICPC

Result test/procedure

1.5

6.2

166

1100

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

6.2

153

996

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

6.2

204

1411

N05AL01

ATC

sulpiride; systemic

2.2

6.2

231

B35.3

ICD-10 Finland

Tinea pedis

1.5

6.2

168

1117

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

2.8

6.2

109

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.4

6.2

174

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

1.9

6.2

374

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

6.2

101

593

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

3.1

6.2

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

2.4

6.2

162

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

2.4

6.2

162

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

6.2

134

847

B37.08

ICD-10 Finland

Other candidal stomatitis

2.5

6.2

144

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

6.2

215

1505

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

6.2

116

708

Z72.1

ICD-10 Finland

Alcohol use

2.2

6.1

232

OAA67, ,

SPAT

0.8

6.1

507

6275

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.6

6.1

146

943

IER01

NOMESCO Finland

Psychoeducation, group

2.7

6.1

121

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

2.7

6.1

121

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

6.1

777

6528

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

3.2

6.1

T48

ICPC

Metabolic, Clarification/discussion RFE/demand

3.4

6.1

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

6.1

249

1792

M77.4

ICD-10 Finland

Metatarsalgia

1.4

6.1

232

1649

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.4

6.1

246

1767

L04AC21

ATC

bimekizumab; systemic

7.7

6.1

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

7.7

6.1

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

6.1

469

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

2.4

6.1

163

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.9

6.1

376

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.6

6.1

143

921

UJF34

NOMESCO Finland

Left colonoscopy

2.8

6.1

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

6.1

222

1567

K76.1

ICD-10 Finland

Chronic passive congestion of liver

12.5

6.1

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.6

6.1

141

906

L28.1

ICD-10 Finland

Prurigo nodularis

2.7

6.1

116

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.1

6.1

253

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

1.8

6.1

434

B37.0

ICD-10 Finland

Candidal stomatitis

2.3

6.1

176

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.6

6.1

130

820

C09AA03

ATC

lisinopril; oral

1.6

6.0

121

750

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

6.0

197

1361

-54

ICPC

Repair/fix-suture/cast/prosth device

1.9

6.0

342

S20.2

ICD-10 Finland

Contusion of thorax

1.5

6.0

187

1279

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

2.9

6.0

SPAT1074

SPAT

Venesection

3.6

6.0

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.8

6.0

435

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

2.5

6.0

134

ICB01, ,

SPAT

2.5

6.0

146

L50.9

ICD-10 Finland

Urticaria, unspecified

1.6

6.0

134

853

S06

ICPC

Rash localized

1.5

6.0

173

1166

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3033658) Prothrombin time (PT) actual/Normal

2222

10403

3.24

323.31

6.2

4.2

93.30

92.42

0.82

2159

10175

(3020682) Albumin/Creatinine [Ratio] in Urine

2535

12873

3.21

319.51

5.1

4.2

7.62

8.27

mg/mmol

0.32

1730

8014

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4282

30669

8.71

311.18

14.7

8.5

93.17

77.81

u/l

71.74

4203

29327

(3032080) INR in Blood by Coagulation assay

3090

17200

3.52

307.65

13.1

12.3

1.14

1.19

inr

7.30

2582

14249

(3007164) IgA [Mass/volume] in Serum or Plasma

2465

8680

5.05

307.65

1.8

1.5

2.82

2.38

g/l

21.46

1941

5538

(40768441) Liver Pathology biopsy report

396

291

14.82

307.65

1.4

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1977

3315

9.83

307.65

2.0

3.0

11.06

10.52

g/l

5.74

1843

3073

(3017143) Hepatitis C virus Ab [Presence] in Serum

1895

5021

5.78

307.65

1.5

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3898

20892

7.34

307.65

9.0

6.8

12.75

11.16

umol/l

7.99

3806

19989

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2003

5501

5.75

307.65

2.5

2.7

25.08

23.40

5.55

1904

5159

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2245

9862

3.54

307.65

1.5

1.3

1.13

1.96

u/ml

4.71

522

2808

(3007566) Smooth muscle Ab [Titer] in Serum

1761

1189

23.65

307.65

1.3

1.2

90.76

155.78

titre

0.66

198

109

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1011

1927

6.47

307.65

1.8

0.30

0.32

mg/l

0.60

472

964

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2034

6002

5.35

307.65

2.5

2.6

2.52

2.34

g/l

35.04

1908

5595

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

980

544

22.73

307.65

1.1

1.43

1.50

g/l

3.80

900

496

(3028026) IgM [Mass/volume] in Serum or Plasma

1873

2568

11.76

307.65

1.5

2.0

1.21

1.31

g/l

1.37

1730

2393

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1637

5770

3.88

307.65

2.1

1.8

1.55

1.45

5.40

1387

5140

(3037522) Nuclear Ab [Titer] in Serum

2196

6178

5.97

307.65

1.6

1.4

489.39

534.86

titre

0.54

494

1284

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

628

380

19.04

307.65

1.2

1.3

—

titre

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

687

313

25.71

307.65

1.1

1.0

285.62

290.71

mg/l

0.48

619

287

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1851

3837

7.48

307.65

2.7

2.4

0.23

0.22

g/l

18.20

1737

3611

(3024561) Albumin [Mass/volume] in Serum or Plasma

3595

17416

6.23

307.65

6.7

5.3

36.92

36.23

g/l

13.01

3482

16462

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

527

768

7.64

307.65

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

377

349

11.70

307.65

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

546

766

7.97

307.65

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3416

14412

6.63

307.65

5.4

3.4

43.45

34.22

u/l

8.95

3281

13667

(3022948) Iron [Moles/volume] in Serum or Plasma

2084

6457

5.14

307.65

2.6

2.7

15.17

13.62

umol/l

15.72

1989

6066

(3034770) Mitochondria Ab [Titer] in Serum

1723

1169

23.22

307.65

1.3

533.53

1131.62

titre

1.57

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1622

4824

4.69

307.65

3.3

2.9

7.97

7.67

umol/l

0.24

1445

4244

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2036

6305

5.06

307.65

1.6

1.7

—

(3012516) Albumin [Mass/volume] in Urine

2474

12704

3.10

299.89

4.2

3.5

44.03

45.34

mg/l

0.11

1758

8035

(3009508) Creatinine [Moles/volume] in Urine

2592

13850

3.05

289.05

4.1

3.5

7.92

7.87

mmol/l

0.19

2248

11905

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

325

335

10.38

283.92

1.2

142.20

200.51

titre

0.55

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2399

12745

2.88

262.26

3.5

2.7

53.43

66.51

u/l

1.41

2230

11918

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3128

19207

3.05

258.97

4.1

3.1

165.67

122.46

ug/l

18.36

2970

18188

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4008

29121

4.36

237.92

7.6

3.3

112.59

46.27

u/l

117.62

3891

27716

(3019069) Monocytes/Leukocytes in Blood

3074

19176

2.89

237.86

9.3

7.0

8.77

8.78

0.02

2946

18093

(3006504) Eosinophils/Leukocytes in Blood

3068

19120

2.89

237.83

9.3

6.9

2.94

2.86

1.16

2941

18014

(3022096) Basophils/Leukocytes in Blood

3067

19113

2.89

237.72

9.4

7.0

0.71

0.70

0.98

2938

17990

(3018010) Neutrophils/Leukocytes in Blood

3076

19356

2.85

231.02

9.1

6.8

56.10

56.70

2.33

2985

18577

(3002030) Lymphocytes/Leukocytes in Blood

3100

19681

2.84

227.04

9.4

6.9

29.10

28.49

2.73

2998

18751

(3001604) Monocytes [#/volume] in Blood

3222

20925

2.89

224.72

9.2

6.7

0.60

0.57

e9/l

8.40

2778

18116

(3006315) Basophils [#/volume] in Blood

3223

20977

2.88

223.04

9.2

6.8

0.04

e9/l

3.48

2781

18150

(3019198) Lymphocytes [#/volume] in Blood

3254

21404

2.86

218.32

9.2

6.8

2.07

1.93

e9/l

2.81

2869

18981

(3013115) Eosinophils [#/volume] in Blood

3274

21652

2.86

216.45

9.5

7.0

0.20

0.19

e9/l

4.66

2866

19056

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

550

1449

4.18

186.80

1.3

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3359

23364

2.71

185.36

11.8

10.3

4.18

4.02

e9/l

3.95

2927

20348

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2848

18416

2.48

182.26

3.3

2.5

71.45

76.62

nmol/l

19.63

2664

16996

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2942

19332

2.50

181.28

8.9

7.6

1.21

mmol/l

0.41

2573

16895

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2672

16907

2.42

177.68

2.6

2.0

96.84

97.29

pmol/l

0.18

1518

8970

(3021879) Hepatitis B virus core Ab [Presence] in Serum

909

3475

3.02

172.50

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

1227

5579

2.65

166.79

3.6

2.6

123.55

131.96

ug/g

0.53

1023

4527

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3877

29781

3.14

163.16

6.3

4.4

14.78

10.93

mm/h

42.73

3722

28155

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1788

9772

2.37

162.28

3.1

2.3

2.90

2.74

mg/l

1.83

1615

8544

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2667

17344

2.31

159.43

8.0

6.9

1.21

mmol/l

0.06

2538

16180

(3026493) Urate [Moles/volume] in Serum or Plasma

1903

10759

2.33

158.80

3.0

2.6

366.01

336.66

umol/l

29.87

1710

9714

(3013826) Glucose [Moles/volume] in Serum or Plasma

3254

23086

2.47

158.28

7.2

5.2

7.43

6.62

mmol/l

53.36

3133

21919

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

250

391

6.71

153.37

1.1

—

(40768797) Stomach Pathology biopsy report

1226

5796

2.53

151.76

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

362

812

4.76

150.31

1.4

1.6

0.73

0.79

g/l

0.50

312

626

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

425

1086

4.22

149.38

1.2

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

252

421

6.28

144.86

1.2

58.46

58.75

u/l

0.02

221

368

(36660697) Celiac disease serology panel - Serum

847

3409

2.83

144.13

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

940

4043

2.67

140.22

3.1

2.6

35.16

52.10

u/l

0.80

819

3467

(3021589) Normoblasts [#/volume] in Blood

2684

18188

2.17

135.68

15.8

11.3

0.00

e9/l

1.37

2161

14857

(3018418) pH of Serum or Plasma

1938

11646

2.16

132.93

4.4

4.5

7.40

1.56

1373

8301

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

351

877

4.26

126.65

1.5

2.1

1.09

0.86

nmol/l

6.44

303

752

(3001186) Copper [Moles/volume] in Serum or Plasma

133

121

11.30

125.94

1.1

1.3

17.69

16.26

umol/l

1.73

117

104

(3023183) Ammonium ion [Moles/volume] in Plasma

354

900

4.18

124.78

5.0

3.2

40.44

35.52

umol/l

2.14

336

835

(3022145) Colonoscopy Study observation

1020

4802

2.45

124.34

1.5

1.4

—

(3018095) Leukocytes [#/volume] in Urine

2228

14455

2.07

121.33

4.6

3.9

122.46

82.89

e6/l

0.66

1549

10108

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

537

1837

3.18

121.00

2.2

2.0

43.54

39.85

u/l

3.37

492

1662

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

102

14.08

110.97

3.2

3.1

46.61

51.39

ug/l

0.03

102

(3002582) Erythrocytes [#/volume] in Urine

1968

12528

2.01

109.50

3.8

3.3

42.94

81.61

e6/l

2.07

1481

9509

(3036481) Cortisol [Moles/volume] in Serum or Plasma

874

4048

2.44

109.01

2.1

2.3

350.81

376.55

nmol/l

2.94

810

3770

(3021960) Folate [Moles/volume] in Serum or Plasma

1713

10443

2.03

107.04

2.0

1.7

19.68

20.34

nmol/l

0.88

1538

8965

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1129

5921

2.21

104.71

2.1

2.2

30.30

29.45

3.90

1098

5779

(3030467) Casts [#/volume] in Urine by Automated count

1746

10795

2.01

104.18

3.6

3.2

0.54

0.37

e6/l

1.67

1258

7838

(36304419) Bacteria [Presence] in Urine

1689

10336

2.01

103.62

3.5

3.1

0.00

106.35

estimate

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1028

5215

2.26

103.28

6.1

6.6

1.04

mmol/l

0.03

976

4883

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1683

10365

1.99

100.73

3.1

3.0

984.34

1009.41

ng/l

0.08

1348

8763

(3023368) Bacteria identified in Blood by Culture

1657

10188

1.99

99.32

5.1

4.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1218

6766

2.10

96.22

3.7

0.79

0.82

mmol/l

12.02

1171

6421

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4290

37693

3.78

91.99

11.1

5.9

42.74

38.82

mmol/mol

102.42

4180

35786

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1859

12205

1.89

89.07

2.7

2.3

185.95

223.55

u/l

1.13

1778

11638

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3774

31368

2.24

87.09

5.7

4.4

14.62

14.67

pmol/l

0.61

3555

29248

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

861

4325

2.22

87.02

3.5

4.8

229.67

241.17

u/l

2.11

819

4124

(3026782) Osmolality of Urine

1246

7210

2.01

86.52

3.2

2.9

534.25

532.09

mosm/kgh2o

0.11

1087

6343

(3000570) Elastase.pancreatic [Mass/mass] in Stool

373

1248

3.17

86.33

1.5

1.4

282.95

287.91

ug/g

0.15

214

728

(3031040) Bacteria [#/volume] in Urine by Automated count

3168

24844

1.92

84.37

5.7

4.3

323.20

1785.09

e6/l

3.25

317

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

148

250

6.09

83.86

1.2

102.20

88.55

u/l

0.41

133

205

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

319

996

3.37

82.63

1.2

1.3

37.02

43.19

u/ml

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

339

1099

3.25

82.62

1.3

1.5

15.06

15.58

iu/ml

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

146

247

6.08

82.59

1.5

6.56

6.22

u/l

0.10

105

201

(3015736) pH of Urine

2347

16906

1.81

80.62

3.8

3.3

6.02

6.19

11.17

1270

9749

(3009261) Glucose [Presence] in Urine by Test strip

2797

21256

1.83

80.18

4.6

3.7

1.69

0.09

estimate

0.49

618

4014

(3035350) Ketones [Presence] in Urine by Test strip

2780

21107

1.83

79.72

4.5

3.7

10.47

4.98

estimate

0.58

684

4294

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

251

685

3.82

79.66

1.1

84.23

16392.90

iu/ml

0.53

143

(3027945) Reticulocytes/Erythrocytes in Blood

807

4081

2.19

79.57

2.8

2.06

1.79

8.47

737

3686

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

302

935

3.39

79.23

1.2

1.3

279.38

262.45

u/ml

0.50

179

577

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1092

6203

2.00

78.83

3.3

3.0

3.15

2.55

e6/l

0.79

494

2961

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

15.22

78.53

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

142

246

5.93

78.39

1.2

30.53

23.70

u/l

0.41

120

197

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

607

2756

2.39

77.18

1.8

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

437

1696

2.75

77.12

1.4

1.6

18.47

14.81

iu/ml

—

(3021601) Nitrite [Presence] in Urine by Test strip

2747

20898

1.80

76.97

4.5

3.7

0.00

estimate

0.13

680

4219

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4186

36895

2.85

76.67

7.4

5.3

1.89

1.86

mu/l

0.73

4011

34602

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

380

1396

2.88

74.31

3.1

3.8

41.02

1499.42

u/ml

1.35

323

1205

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

293

927

3.31

74.17

1.3

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1454

9236

1.85

74.03

2.0

1.8

1.13

1.12

mg/l

0.02

1124

7101

(3044640) Blood type and Crossmatch panel - Blood

1851

12650

1.79

73.86

2.9

2.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4361

39459

4.10

73.84

25.1

14.9

18.24

22.90

mg/l

27.20

4042

32186

(3019309) Folate [Moles/volume] in Red Blood Cells

999

5622

2.00

73.38

1.9

1.7

1099.72

1161.11

nmol/l

1.33

759

4374

(3026008) Bacteria identified in Urine by Culture

1619

10664

1.81

72.94

3.8

3.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

130

224

5.95

72.16

1.2

1.1

89.74

73.70

u/l

1.78

115

207

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1143

6789

1.92

71.36

3.2

2.9

1.04

0.97

e6/l

0.20

552

3563

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4262

38150

3.10

71.32

7.6

4.9

6.61

5.88

mmol/l

141.63

4089

35641

(3048929) Epstein Barr virus Ab [Presence] in Serum

390

1491

2.77

70.67

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

128

223

5.88

70.24

1.2

1.1

24.29

18.70

u/l

0.98

113

205

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

126

7.85

70.12

1.3

1.7

11.13

8.74

ug/l

4.12

126

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

387

1480

2.77

70.06

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

287

930

3.23

69.80

1.2

1.4

14.24

19.22

u/ml

—

(3002032) Base excess in Venous blood by calculation

729

3728

2.14

69.05

4.3

4.1

1.34

1.85

mmol/l

2.65

642

3277

(3020779) Urea [Moles/volume] in Serum or Plasma

698

3535

2.15

67.68

7.6

8.4

9.23

9.01

mmol/l

0.33

667

3420

(3015377) Calcium [Moles/volume] in Serum or Plasma

1931

13619

1.73

67.06

3.2

3.6

2.37

2.36

mmol/l

3.58

1784

12541

(3019550) Sodium [Moles/volume] in Serum or Plasma

4385

40102

4.27

67.04

28.4

16.9

139.49

139.77

mmol/l

12.16

4357

39433

(3023420) DNA double strand Ab [Units/volume] in Serum

443

1854

2.54

66.83

1.8

1.9

10.91

6.47

iu/ml

0.99

455

(3012544) pH of Venous blood

745

3888

2.10

66.72

4.3

4.0

7.38

0.14

438

2158

(3020630) Protein [Mass/volume] in Serum or Plasma

630

3085

2.21

66.42

2.1

2.9

67.98

66.76

g/l

3.25

574

2873

(3023103) Potassium [Moles/volume] in Serum or Plasma

4386

40216

4.20

64.68

28.8

17.0

3.95

3.96

mmol/l

2.76

4355

39468

(3007853) Bacteria identified in Skin by Aerobe culture

848

4691

1.99

64.50

2.0

1.8

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

558

2631

2.28

64.38

10.5

9.2

24.33

24.93

mmol/l

3.12

553

2616

(3021447) Carbon dioxide [Partial pressure] in Venous blood

729

3825

2.08

64.16

4.3

4.0

5.75

5.84

kpa

1.43

715

3718

(46235355) HIV 1 and 2 tests - Meaningful Use set

1238

7759

1.82

64.12

1.9

—

(3000850) Epithelial cells [#/volume] in Urine

1337

8576

1.79

64.09

2.9

2.7

6.25

5.61

e6/l

0.95

1198

7829

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2378

17900

1.69

63.79

2.3

1.9

1.81

1.41

mmol/l

45.36

2017

15333

(3014051) Protein [Presence] in Urine by Test strip

1694

11710

1.71

61.89

3.3

2.8

0.06

0.02

0.36

205

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

259

850

3.17

61.57

1.2

1.5

156.86

151.67

au/ml

0.23

254

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

531

2508

2.27

60.84

3.4

3.6

5.09

5.16

kpa

1.46

516

2425

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1022

6134

1.86

60.35

1.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1447

9635

1.74

60.15

2.8

2.3

—

(3009343) pH of Capillary blood

517

2436

2.27

59.52

3.4

3.6

7.41

7.42

0.49

443

2023

(3000991) Gas panel - Venous blood

655

3396

2.09

59.17

12.1

10.0

—

(3023520) Reticulocytes [#/volume] in Blood

611

3088

2.13

59.03

2.5

2.8

83.83

71.35

e9/l

9.53

416

2264

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4249

38550

2.74

58.20

24.5

14.1

86.35

84.58

ml/min/173m2

6.75

4039

35667

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2400

18369

1.65

58.19

3.2

2.7

—

estimate

—

(40758558) Short blood count panel - Blood

1769

12529

1.68

58.00

7.3

6.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1214

7772

1.77

57.46

2.2

1.7

32887633.26

34990643.01

pmol/l

0.04

1046

6639

(3002179) Metamyelocytes/Leukocytes in Blood

666

3522

2.05

56.87

5.3

4.6

0.70

0.01

204

1028

(3004588) Protein electrophoresis panel - Serum or Plasma

512

2466

2.21

55.71

2.0

2.6

—

(3017181) Myelocytes/Leukocytes in Blood

685

3689

2.01

55.51

5.5

4.8

0.78

0.96

1.04

214

1081

(3042936) Bacteria identified in Isolate by Culture

946

5677

1.84

55.28

2.6

2.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

577

2924

2.12

55.14

3.7

4.1

79.85

85.79

ng/l

1.01

520

2568

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

380

1617

2.47

55.01

1.8

1.44

1.54

g/l

1.31

331

1400

(3014111) Lactate [Moles/volume] in Serum or Plasma

664

3547

2.02

55.01

10.6

8.6

1.62

1.31

mmol/l

7.37

655

3478

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1161

7416

1.76

54.99

4.5

3.6

335.07

602.43

ng/l

0.83

845

5401

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

456

2112

2.29

54.49

3.3

3.4

1.65

1.71

mmol/l

0.13

327

1604

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

706

3866

1.98

54.48

3.2

4.4

7.83

23.12

ug/l

2.16

548

3103

(3044889) 12 lead EKG panel

3351

28216

1.73

54.11

4.7

3.8

0.00

8409.24

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

165

445

3.81

53.14

1.4

1.3

1.79

1.47

nmol/l

2.55

144

406

(3021440) Promyelocytes/Leukocytes in Blood

654

3533

2.00

52.31

5.7

4.8

0.08

0.12

1.00

185

925

(3025159) Blasts/Leukocytes in Blood

660

3592

1.98

51.63

5.8

5.0

0.03

0.23

1.37

182

875

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

316

1273

2.59

51.26

1.3

11.20

5.36

u/ml

0.32

119

(3015171) Extractable nuclear Ab [Units/volume] in Serum

388

1724

2.37

50.94

1.4

1.3

0.39

1.22

u/ml

1.60

136

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

260

952

2.84

50.82

3.9

6.2

936.96

600.01

iu/ml

0.22

138

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

329

1358

2.53

50.73

1.3

62.41

36.33

u/ml

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1952

14526

1.61

50.36

4.2

3.5

66.20

85.78

ng/l

0.17

1298

9412

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

353

1517

2.44

49.90

1.9

2.5

7.40

7.30

g/l

0.50

326

1411

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

352

1515

2.44

49.59

1.9

2.5

4.09

3.73

g/l

4.15

326

1412

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

352

1515

2.44

49.59

1.9

2.5

4.51

4.22

g/l

5.58

326

1409

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

313

1277

2.56

49.43

1.3

3.65

8.38

u/ml

1.71

192

(3020191) Ethanol [Moles/volume] in Serum or Plasma

145

379

3.92

48.82

1.5

0.63

1.30

promille

6.53

128

299

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

338

1442

2.45

48.52

2.0

2.5

2.79

2.90

g/l

1.56

311

1337

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

269

1029

2.72

48.35

1.2

1.3

9.05

3.05

u/ml

0.37

(3023487) Leukocytes [#/volume] in Peritoneal fluid

159

5.69

47.58

3.4

2.2

286.78

765.67

e6/l

3.18

115

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1222

8221

1.67

46.55

1.5

1.3

41.06

27.94

iu/ml

1.10

341

2561

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

465

2310

2.13

46.43

13.5

11.0

24.15

24.32

mmol/l

0.48

459

2277

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

768

4565

1.82

45.36

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

358

1616

2.32

45.19

1.6

16.04

14.36

u/ml

0.16

412

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1144

7614

1.67

45.19

1.4

1.3

8.31

10.35

u/ml

0.45

369

3124

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

736

4336

1.83

44.70

1.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1128

7501

1.67

44.62

2.7

2.9

2.46

2.44

mmol/l

3.22

996

6763

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

310

1330

2.43

43.88

2.1

2.5

0.35

1.02

g/l

4.30

275

1165

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

303

1291

2.44

43.54

1.9

2.5

10.95

10.19

g/l

2.06

276

1175

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

280

1152

2.53

43.37

2.0

2.4

0.00

0.02

g/l

1.99

253

1044

(3027801) Oxygen [Partial pressure] in Arterial blood

744

4443

1.81

43.08

11.2

8.7

11.80

12.73

kpa

5.87

727

4296

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

743

4444

1.80

42.77

11.3

8.7

5.08

5.12

kpa

0.46

726

4298

(3024354) Oxygen [Partial pressure] in Venous blood

576

3184

1.93

42.53

3.5

3.4

4.93

4.60

kpa

2.94

563

3089

(3019977) pH of Arterial blood

741

4441

1.80

42.33

11.3

8.8

7.41

0.01

363

2439

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

257

1029

2.59

42.11

2.1

2.5

0.00

g/l

-0.00

238

977

(3003396) Base excess in Arterial blood by calculation

735

4406

1.80

41.92

11.3

8.7

0.51

0.90

mmol/l

1.76

636

3652

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4152

38087

2.12

41.68

5.8

4.2

1.78

1.32

mmol/l

126.38

3939

35744

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

203

724

2.89

41.61

1.2

1.3

113.68

518.25

titre

2.76

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4328

40431

2.71

41.02

8.1

5.6

2.69

2.80

mmol/l

13.80

4171

38290

(3000494) Fungus identified in Specimen by Culture

834

5216

1.73

40.98

1.6

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

275

1155

2.47

40.73

2.4

2.1

11.55

11.56

mg/l

0.01

261

1084

(40760892) CBC W Ordered Manual Differential panel - Blood

1364

9696

1.58

40.41

7.0

4.8

—

(40768804) Tissue Pathology biopsy report

2099

16411

1.52

40.35

2.3

2.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

426

2155

2.08

40.35

1.8

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

114

6.13

39.99

1.6

1.5

12.00

11.70

g/l

0.09

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

320

1450

2.30

39.94

1.7

1.5

0.62

0.29

iu/ml

0.34

252

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

266

1112

2.48

39.79

2.0

2.4

0.00

g/l

-0.00

238

978

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

534

2957

1.91

39.04

4.1

4.2

1.22

1.23

mmol/l

0.71

478

2588

(3022313) Gas panel - Capillary blood

356

1713

2.17

38.36

3.5

3.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4287

40041

2.40

37.62

7.0

5.0

4.55

4.74

mmol/l

28.71

4154

38055

(3002331) Protein [Mass/volume] in Peritoneal fluid

6.40

37.53

1.6

1.4

23.60

24.54

g/l

0.15

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4271

39859

2.33

37.02

6.9

5.0

1.26

1.46

mmol/l

242.51

4100

37693

(3016502) Oxygen saturation in Arterial blood

656

3972

1.76

35.71

12.1

9.1

95.56

95.94

1.00

641

3854

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

139

5.25

35.43

2.7

2.0

2581.24

19656.27

e6/l

0.65

(3011397) Hemoglobin [Presence] in Urine by Test strip

1313

9502

1.54

34.88

3.9

3.6

0.63

0.14

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

242

1030

2.43

34.78

1.3

78.95

47.77

u/ml

0.78

106

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

195

751

2.67

34.53

1.6

3.0

331.11

1378.33

u/ml

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4427

42167

3.59

34.46

23.1

12.0

48.98

27.43

u/l

307.65

4385

41210

(3044007) Cell count panel - Peritoneal fluid

143

5.10

34.32

3.2

2.0

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3747

33727

1.65

34.19

31.4

18.3

13.80

13.51

31.54

3730

33303

(3041096) Erythrocytes [Presence] in Urine by Automated

1543

11608

1.50

33.91

4.1

3.1

0.89

0.13

estimate

0.68

593

3344

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

289

1344

2.23

33.82

1.7

1.8

0.24

g/l

0.51

275

1283

(3017732) Neutrophils [#/volume] in Blood

824

5415

1.64

32.83

3.3

4.29

4.54

e9/l

0.62

750

4804

(1616796) Gas panel - Central venous blood

203

821

2.54

32.54

3.4

3.9

—

(3011985) Renin [Units/volume] in Plasma

168

620

2.78

32.32

1.4

81.60

63.95

mu/l

0.40

157

558

(40761536) Microorganisms panel - Urine sediment

528

3093

1.80

31.96

4.3

3.9

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

614

3760

1.73

31.87

12.7

9.6

121.60

122.99

g/l

0.79

607

3683

(3039162) Centromere protein B Ab [Units/volume] in Serum

154

547

2.88

31.82

1.3

59.33

53.81

u/ml

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4426

42315

3.36

30.96

32.6

18.8

76.11

75.53

umol/l

0.51

4407

41942

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

289

1394

2.15

30.84

1.7

1.8

1.31

1.20

g/l

6.13

275

1331

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

157

575

2.79

30.65

1.3

316.03

333.09

pmol/l

0.21

136

495

(3035933) Granulocytes/Leukocytes in Blood

214

914

2.41

30.51

4.2

3.3

56.25

57.63

0.97

214

914

(3034860) Kappa light chains.free [Mass/volume] in Serum

258

1195

2.23

30.46

2.6

3.9

44.91

55.00

mg/l

0.81

218

1019

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

268

1264

2.19

30.26

2.6

2.7

3.57

g/l

0.01

258

1208

(3013139) Helicobacter pylori Ag [Presence] in Stool

497

2907

1.80

30.16

1.2

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

257

1198

2.21

29.87

2.6

3.9

37.94

52.36

mg/l

0.78

216

1023

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

150

544

2.82

29.83

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

235

3.84

29.62

1.7

1.5

1091995.00

1264963.50

iu/ml

—

(3025941) Bacteria identified in Stool by Culture

417

2325

1.87

29.52

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

198

831

2.45

29.34

2.4

3.7

29.85

738.25

u/ml

1.52

182

762

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

236

1074

2.26

29.07

1.1

2.14

6.29

eliau/ml

2.19

149

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

238

1088

2.25

29.00

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

472

2753

1.80

28.86

3.2

3.5

4.56

4.52

pmol/l

0.40

422

2505

(40768443) Skin Pathology biopsy report

336

1758

1.98

28.75

1.3

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

276

1357

2.10

28.00

3.7

3.5

24.64

24.85

mmol/l

0.66

263

1271

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

158

609

2.65

27.95

1.1

1.2

5.17

7.16

u/ml

—

(1002224) Polysomnography panel

436

2525

1.80

27.24

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

106

337

3.20

26.60

1.1

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

236

3.65

26.34

1.4

1.72

1.25

nmol/l

1.78

174

(40759836) Histone Ab [Presence] in Serum by Immunoblot

111

366

3.08

26.20

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

225

1050

2.20

26.07

2.9

3.1

3.70

1.99

index

0.66

115

553

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

113

378

3.04

26.02

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

227

1066

2.19

25.90

2.7

3.6

1.55

3.10

ratio

1.89

120

598

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

275

1390

2.04

25.89

2.2

2.3

84.92

94.08

5.84

262

1339

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

259

1289

2.07

25.43

3.4

3.8

1.57

1.44

mg/l

1.53

233

1205

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

106

347

3.10

25.34

1.1

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

592

3804

1.64

25.26

3.6

3.2

—

(4035726) Immunohistochemistry procedure

557

3524

1.66

25.26

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

136

513

2.70

25.13

1.3

1.4

6.68

6.81

g/l

0.18

102

365

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

167

700

2.44

24.83

1.4

1.3

17.21

38.04

u/l

2.70

147

604

(3010421) pH of Blood

249

1234

2.08

24.72

3.8

4.0

7.41

0.68

244

1220

(3024139) IgG subclass 3 [Mass/volume] in Serum

135

512

2.69

24.69

1.3

1.4

0.40

0.38

g/l

0.24

363

(3028192) IgG subclass 2 [Mass/volume] in Serum

135

513

2.68

24.59

1.3

1.4

2.98

2.95

g/l

0.08

367

(3036489) Thrombin time

303

1616

1.94

24.47

2.0

2.2

22.06

21.05

1.07

272

1421

(3014765) Yersinia sp identified in Stool by Organism specific culture

228

1105

2.12

24.01

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

106

362

2.97

23.57

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

106

362

2.97

23.57

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

228

1113

2.10

23.56

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

102

341

3.04

23.54

1.1

1.2

87.86

83.16

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

103

351

2.98

23.00

1.2

—

(4062490) Immunoglobulin typing, IgG

131

508

2.63

22.94

1.3

1.4

—

(3002256) Pathology report gross observation

770

5373

1.52

22.84

1.4

1.3

—

(3012501) Base excess in Blood by calculation

173

765

2.31

22.83

4.3

2.47

2.53

mmol/l

0.11

113

515

(3013290) Carbon dioxide [Partial pressure] in Blood

173

766

2.31

22.76

4.3

4.99

5.03

kpa

0.22

168

752

(3027315) Oxygen [Partial pressure] in Blood

173

769

2.30

22.55

4.3

8.97

8.66

kpa

1.43

168

754

(3004119) Hemoglobin [Mass/volume] in Venous blood

402

2400

1.74

22.51

3.4

131.54

131.06

g/l

0.15

392

2333

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

223

1101

2.08

22.37

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

115

423

2.76

22.34

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

427

2598

1.71

22.33

2.6

2.8

148.89

159.46

ng/l

0.22

378

2350

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

247

1267

2.00

22.31

2.3

2.6

198.46

189.49

0.76

237

1210

(3021387) Prolactin [Units/volume] in Serum or Plasma

281

1509

1.92

22.22

1.8

1.7

284.23

293.69

mu/l

0.24

258

1377

(3034274) Bile acid [Moles/volume] in Serum --fasting

111

404

2.79

22.00

2.3

2.1

13.19

6.67

umol/l

1.89

292

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

184

3.74

21.93

1.1

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

265

1403

1.94

21.86

2.5

2.4

583.33

665.96

ug/l

0.15

242

1331

(3005322) IgE [Units/volume] in Serum or Plasma

475

2990

1.66

21.83

1.5

1.3

307.90

228.92

u/ml

0.53

455

2783

(3037756) Immunofixation for Serum or Plasma

167

743

2.30

21.73

1.4

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

222

1116

2.04

21.21

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1074

8104

1.43

21.17

1.7

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1927

16032

1.35

20.88

4.5

3.6

0.21

0.07

estimate

0.37

587

3477

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

227

1160

2.01

20.73

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

249

1323

1.93

20.32

1.5

1.4

9.62

10.40

u/l

0.41

205

1056

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

113

434

2.64

20.21

1.1

1.2

48.67

39.99

u/ml

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

176

834

2.16

19.66

2.2

2.4

136.58

123.92

ug/min

0.12

104

517

(3003327) Ova and parasites identified in Stool by Light microscopy

282

1578

1.84

19.61

1.8

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3005

26860

1.36

19.57

3.4

3.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

472

3047

1.61

19.53

1.2

124.63

141.48

u/ml

0.38

158

1164

(3004616) Nuclear Ab [Presence] in Serum

130

546

2.42

19.31

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

156

713

2.23

19.07

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

156

713

2.23

19.07

1.4

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

329

2.83

18.89

1.3

11.26

8.96

mmol/l

4.24

312

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

166

785

2.16

18.66

1.7

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

1409

11324

1.36

18.53

4.8

3.9

0.00

estimate

0.41

633

3953

(3006184) Hemoglobin [Mass/volume] in Capillary blood

184

912

2.06

18.29

2.1

2.3

129.85

131.26

g/l

0.28

137

705

(3037121) Protein [Mass/volume] in Urine

236

1284

1.88

17.94

3.5

326.99

438.12

mg/l

0.55

111

597

(3033942) Copper [Moles/time] in 24 hour Urine

15.35

17.93

1.3

1.1

0.96

0.87

umol/24h

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

215

1135

1.94

17.90

2.8

3.6

0.31

0.34

iu/ml

0.60

119

604

(3038026) Centromere Ab [Units/volume] in Serum

323

2.79

17.80

1.1

1.2

1.28

53.86

u/ml

—

(3000093) Morphology [Interpretation] in Blood Narrative

356

2.68

17.34

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

182

3.38

17.07

3.5

3.8

8.42

8.77

mg/l

0.12

149

(3019225) pH of Specimen

513

3486

1.53

16.89

4.8

4.2

7.38

7.35

6.33

410

2541

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

137

628

2.22

16.67

1.3

1.4

0.62

3.41

nmol/l

0.50

132

609

(3028707) Methadone [Presence] in Urine by Screen method

163

801

2.07

16.61

2.3

2.9

—

(37208534) Antinuclear antibody arbitrary concentration in serum

133

3.79

16.60

1.0

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

258

1485

1.78

16.35

1.9

2.0

2.05

1.91

ug/l

0.11

238

1351

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

283

1673

1.74

16.35

6.0

5.5

1.64

1.66

0.14

275

1585

(3004716) Salmonella sp identified in Stool by Organism specific culture

334

2076

1.66

16.02

1.5

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

180

3.31

15.96

3.1

2.1

8.32

9.48

mg/l

0.83

154

(3024928) Oxygen saturation in Venous blood

197

1052

1.91

15.87

3.0

3.4

67.15

62.65

2.18

189

1026

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

162

809

2.04

15.82

1.4

1.6

—

(3000330) Specific gravity of Urine by Test strip

294

1773

1.70

15.81

4.1

3.2

1.02

ratio

3.52

272

1611

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

129

3.75

15.72

2.2

1.7

189.83

145.40

au/ml

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

123

553

2.26

15.70

1.3

1.4

0.17

0.21

nmol/l

0.67

441

(4146454) Self-monitoring of blood glucose

400

2.48

15.55

2.8

2.7

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

459

3099

1.54

15.52

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

137

647

2.15

15.50

1.3

1.4

0.17

0.30

nmol/l

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

161

3.38

15.16

3.1

133.72

123.96

au/ml

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

353

2258

1.61

15.09

1.1

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

149

736

2.06

15.01

5.0

3.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

104

459

2.30

13.91

2.5

2.4

1.18

1.34

g/24h

0.30

277

(3004809) Band form neutrophils/Leukocytes in Blood

127

611

2.11

13.74

2.9

3.4

1.06

1.60

1.41

118

558

(3007930) Methemoglobin/Hemoglobin.total in Blood

255

1538

1.70

13.72

6.2

5.9

0.86

0.88

0.31

247

1453

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

421

2870

1.51

13.57

1.3

37.74

53.12

au/ml

0.54

210

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

300

1894

1.63

13.53

2.5

2.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

447

3096

1.49

13.34

2.4

13.03

21.07

au/ml

2.19

367

(3003181) Sodium [Moles/volume] in Urine

137

688

2.02

13.23

1.5

1.4

54.25

61.78

mmol/l

1.19

106

548

(3036603) Volume of Urine

322

2.51

13.14

1.6

1.5

1971.25

2020.06

0.17

317

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

227

2.80

12.88

1.5

1.7

2.34

6.14

nmol/l

0.99

180

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

200

2.92

12.84

2.1

2.6

199.04

162.68

umol/l

0.16

108

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

233

2.73

12.28

1.2

—

(3007461) Platelets [#/volume] in Blood

4437

43419

2.28

12.16

39.2

22.6

249.98

254.22

e9/l

3.69

4390

42687

(3019420) Tryptase [Mass/volume] in Serum or Plasma

269

2.59

12.13

1.4

1.5

11.61

8.18

ug/l

0.27

239

(3035941) MCH [Entitic mass]

4437

43428

2.27

12.00

38.9

22.5

30.31

0.01

4420

43073

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4437

43429

2.27

11.98

38.9

22.5

90.92

90.85

0.45

4420

43073

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4437

43433

2.26

11.91

40.1

23.1

41.19

41.33

0.28

4419

43054

(3010838) Calcium [Moles/time] in 24 hour Urine

144

764

1.91

11.91

2.0

5.90

5.16

mmol/24h

1.55

136

686

(3026361) Erythrocytes [#/volume] in Blood

4437

43435

2.26

11.88

39.0

22.6

4.60

4.55

e12/l

6.36

4380

42603

(3010813) Leukocytes [#/volume] in Blood

4437

43438

2.26

11.82

39.1

22.6

7.09

6.60

e9/l

29.62

4382

42594

(3000963) Hemoglobin [Mass/volume] in Blood

4437

43446

2.25

11.68

39.4

22.7

137.95

137.21

g/l

2.45

4421

43089

(3030981) Hyaline casts [#/volume] in Urine by Automated count

444

3152

1.45

11.66

3.0

2.4

0.42

0.43

e6/l

0.04

424

2997

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

234

1442

1.66

11.63

1.3

232.31

218.92

miu/ml

0.20

680

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

180

2.91

11.47

2.6

2.0

81.91

159.84

ug/min

0.54

(3023323) Follitropin [Units/volume] in Serum or Plasma

344

2330

1.52

11.42

1.4

27.80

29.78

iu/l

0.59

285

2003

(3006653) Thiamine [Moles/volume] in Blood

237

2.64

11.36

1.4

1.3

136.00

134.94

nmol/l

0.07

237

(3049717) Cytology report of Urine Cyto stain

209

1262

1.69

11.24

2.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

109

536

2.06

11.21

1.2

1.4

—

nmol/l

—

(3011288) Drugs identified in Urine by Screen method Nominal

216

1318

1.67

11.16

2.5

3.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

291

1916

1.55

11.00

1.5

—

(3000012) Reticulocyte production index

101

487

2.10

10.95

2.2

1.09

0.92

0.88

321

(3022621) pH of Urine by Test strip

430

3075

1.44

10.85

3.2

2.4

5.94

6.09

3.29

303

2000

(3042733) HLA Ab [Presence] in Serum

170

2.90

10.79

2.1

4.9

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

150

3.02

10.63

1.2

1.5

420.96

310.63

nmol/24h

0.11

150

(3045414) Leukocytes [Presence] in Urine

505

3742

1.39

10.41

2.3

2.1

0.03

0.01

estimate

0.31

827

(3032773) Endomysium IgG Ab [Titer] in Serum

426

2.14

10.26

1.1

—

titre

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

331

2.29

10.14

3.1

2.4

1.20

mmol/l

0.12

323

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

250

2.46

9.74

2.0

2.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

599

4609

1.35

9.73

6.2

4.7

27.95

31.70

14.61

494

3164

(21494755) Public health laboratory ask at order entry panel

340

4768

0.69

9.71

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

201

1255

1.63

9.54

2.4

2.7

—

(3041354) Potassium [Moles/volume] in Venous blood

342

2.21

9.41

3.1

2.3

4.04

4.01

mmol/l

0.23

334

(3035285) Chloride [Moles/volume] in Venous blood

342

2.21

9.41

3.1

2.3

104.97

105.43

mmol/l

0.40

334

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

489

2.01

9.38

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

455

2.04

9.38

1.3

1.5

—

(3024471) HLA-A [Type]

145

2.91

9.37

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

4.23

9.36

1.8

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

128

709

1.83

9.34

1.3

1.2

4.44

4.09

u/ml

0.10

313

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

215

1372

1.60

9.34

2.2

2.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

167

1001

1.69

9.28

1.6

1.7

10799.69

11025.56

e6/l

0.03

113

705

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

457

2.03

9.27

1.3

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

144

829

1.76

9.25

2.1

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

232

1513

1.56

9.18

2.0

2.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

459

2.03

9.17

1.3

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

177

1083

1.66

9.11

1.4

—

(3024932) HLA-DR beta [Type]

143

2.88

9.00

1.0

1.1

—

(3017354) Segmented neutrophils/Leukocytes in Blood

378

2.11

8.81

2.5

3.5

54.86

56.84

0.40

334

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

250

2.38

8.80

1.3

1.5

22.60

22.09

u/ml

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

333

2.18

8.76

1.1

1.2

111.44

111.82

pmol/l

0.02

333

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

474

1.98

8.75

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

197

1254

1.60

8.67

2.0

1.9

—

(4198724) Urine methamphetamine measurement

210

2.49

8.61

1.7

3.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

316

2.20

8.60

1.4

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

485

1.96

8.55

1.3

1.4

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

6.92

8.53

2.6

2.0

70.50

56.39

—

(4281824) Cell count and differential, peritoneal fluid

452

1.99

8.47

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

482

1.95

8.36

1.3

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

127

727

1.77

8.35

1.3

1.2

2.60

3.76

u/ml

0.63

257

(3004775) Volume in Urine collected for unspecified duration

276

2.26

8.29

2.0

2.3

708.62

626.30

0.61

193

(3000764) Benzodiazepines [Presence] in Urine

282

1960

1.47

8.28

1.9

2.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

100

533

1.90

8.28

3.0

3.3

0.77

0.80

nmol/l

0.38

431

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

168

2.63

8.18

4.8

2.7

0.60

0.62

mmol/l

0.58

168

(3027944) Amphetamines [Presence] in Urine

279

1940

1.47

8.18

1.9

2.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

166

1029

1.64

8.16

1.4

1.7

—

(3028300) Cannabinoids [Presence] in Urine

283

1975

1.46

8.14

1.9

2.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

146

877

1.69

8.10

2.1

1.8

—

(3003694) ABO and Rh group [Type] in Blood

1341

11626

1.22

8.04

1.5

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

164

2.64

8.02

2.4

5.6

78.24

65.91

mg/l

0.52

116

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

423

5550

0.74

8.01

2.1

2.0

4.10

3.56

ratio

9.72

320

4261

(3027008) Opiates [Presence] in Urine

281

1968

1.46

7.94

1.9

2.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

505

1.90

7.94

1.3

1.7

—

(3008898) HLA-B27 [Presence]

238

1613

1.50

7.93

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

368

2.06

7.88

1.7

2.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

118

674

1.77

7.84

1.1

122.86

116.61

1.10

105

619

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

122

704

1.75

7.83

1.5

1.8

—

(4195642) Thrombophilia screening test

118

675

1.77

7.81

1.2

—

(21494434) Karyotype in Bone marrow

330

2.11

7.76

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

261

1814

1.47

7.68

1.9

2.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

169

1076

1.59

7.48

1.4

1.7

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

302

4134

0.71

7.46

1.8

1.7

3.61

3.52

mmol/l

0.61

208

2830

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.90

7.42

1.0

1.1

0.01

0.03

u/ml

0.72

(3045424) Erythrocytes [Presence] in Urine

273

1932

1.44

7.32

2.4

2.2

3.68

0.39

estimate

0.42

650

(3017446) Testosterone [Moles/volume] in Serum or Plasma

504

3937

1.32

7.32

3.2

2.4

12.02

14.01

nmol/l

6.65

461

3638

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

393

2962

1.36

7.28

2.2

2.3

6.70

8.12

ug/l

0.74

349

2673

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

121

717

1.71

7.11

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

357

2.00

7.02

2.8

3.0

54.44

58.17

mg/l

0.04

257

(3044927) Protein electrophoresis panel - Urine

330

2.05

7.01

1.4

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

406

1.94

6.99

11.9

4.3

10.32

7.17

mmol/l

1.06

345

(3020491) Glucose [Moles/volume] in Blood

271

2.16

6.96

1.8

7.50

6.74

mmol/l

0.82

181

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

172

2.46

6.83

2.0

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

172

2.46

6.83

2.0

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

111

650

1.73

6.82

6.7

6.1

353.48

371.03

umol/l

0.60

579

(3004347) Hepatitis D virus Ab [Presence] in Serum

8.26

6.81

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

110

643

1.73

6.80

1.3

1.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

181

1198

1.53

6.79

2.1

3.09

8.58

iu/l

0.66

521

(3042631) Mycobacterium sp identified in Specimen

492

1.83

6.65

3.3

2.8

—

(3047181) Lactate [Moles/volume] in Blood

173

1140

1.54

6.63

7.1

6.6

1.64

1.29

mmol/l

3.51

155

1003

(3013945) Hepatitis B virus e Ab [Presence] in Serum

6.42

6.62

1.4

1.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

314

2330

1.37

6.43

8.2

7.3

23.97

24.52

mmol/l

1.44

304

2237

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

3.51

6.43

3.4

2.0

8.78

7.69

mmol/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

5.94

6.29

1.6

1.9

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

18.03

6.26

2.2

2.0

26.09

17.80

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

149

2.50

6.26

1.1

1.0

3.29

12.18

u/ml

3.10

102

(3002079) Sodium [Moles/time] in 24 hour Urine

211

2.24

6.25

1.3

160.62

170.91

mmol/24h

0.37

211

(3002619) Bacteria identified in Specimen by Culture

2.87

6.19

1.4

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

353

1.94

6.19

1.4

1.3

0.29

1.06

u/ml

1.86

196

(3008757) Leukocyte morphology finding [Identifier] in Blood

354

1.93

6.14

2.3

4.1

—

(3051611) Lipemic interference index of Serum or Plasma

348

1.94

6.09

3.4

3.2

20.41

13.24

index

1.66

219

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

233

1659

1.43

6.09

2.0

33.68

38.78

nmol/l

2.72

228

1614

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

266

2.08

6.09

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

535

4317

1.27

6.04

2.2

2.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

449

1.82

6.04

1.6

1.7

55.59

56.31

0.05

280

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

261

2.08

5.99

1.5

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

295

2.01

5.98

1.3

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

142

924

1.55

5.81

1.5

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

231

1664

1.41

5.68

1.8

4.14

4.45

mg/l

0.24

208

1244

(3038177) Helicobacter pylori Ab [Presence] in Serum

116

724

1.62

5.66

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

576

4728

1.25

5.62

2.3

2.1

—

(3008295) Osmolality of Serum or Plasma

467

1.77

5.62

1.3

1.4

278.79

278.80

mosm/kgh2o

0.00

363

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

187

1302

1.46

5.54

2.7

2.3

2390.17

4991.77

u/l

1.37

498

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

5.85

5.52

3.1

2.0

18.00

15.69

—

(3026250) Tacrolimus [Mass/volume] in Blood

230

2.10

5.48

38.1

38.2

6.88

7.43

ug/l

1.37

208

(3024891) Influenza virus A+B Ag [Presence] in Specimen

169

1159

1.48

5.42

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

429

1.78

5.38

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

267

2.00

5.31

1.2

1.1

1.06

ratio

0.00

215

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

156

2.32

5.25

1.9

1.8

39.46

40.66

g/l

0.57

156

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

229

2.06

5.16

1.1

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.94

5.13

1.2

1.1

0.81

0.71

umol/24h

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

192

1365

1.42

5.12

1.4

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

505

1.70

5.06

1.3

1.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

159

2.27

5.04

1.1

1.2

0.31

0.30

g/l

0.48

132

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.77

5.03

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

185

2.17

5.02

1.6

1.5

3.70

3.72

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

110

700

1.59

5.00

1.2

1.1

1.41

0.94

—

(4268621) Lupus anticoagulant assay

507

1.69

4.99

2.4

2.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1297

11604

1.17

4.97

4.8

4.7

1.72

2.06

ug/l

1.44

1185

10639

(3035320) C reactive protein [Mass/volume] in Body fluid

310

1.88

4.92

2.8

2.4

17.86

30.83

mg/l

2.19

209

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

617

1.62

4.92

1.1

3.51

3.33

eliau/ml

0.06

308

(3009871) Measles virus Ab [Titer] in Serum

200

2.11

4.91

1.5

1.7

4106.67

3661.94

titre

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

525

1.67

4.90

1.1

104.00

97.84

1.29

494

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

332

1.85

4.89

1.6

1.5

14.39

12.05

umol/l

1.19

312

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.56

4.86

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

606

1.61

4.78

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

196

2.10

4.75

1.0

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

485

1.68

4.71

3.2

3.4

4.39

16.89

nmol/l

0.57

473

(3017704) Immunofixation for Urine

197

2.09

4.70

1.5

1.8

—

(3016750) Collection duration of Urine

219

2.02

4.60

2.0

2.2

499.55

491.69

min

0.22

166

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

413

3342

1.26

4.57

2.8

2.6

68.97

70.03

ml/min/173m2

0.20

180

1341

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

206

2.05

4.57

1.5

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.56

4.54

1.2

363.07

276.40

pmol/l

0.38

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

214

2.02

4.50

1.2

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

173

1238

1.41

4.49

4.5

3.9

1.73

1.37

mmol/l

1.47

167

1220

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

123

2.37

4.48

1.2

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

166

1183

1.42

4.41

1.2

3.17

4.11

0.82

185

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

170

2.13

4.33

1.0

1.1

4.82

6.21

u/ml

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

204

2.02

4.31

1.5

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

118

791

1.50

4.31

1.3

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

267

1.88

4.30

1.4

1.5

74.80

78.03

umol/l

0.42

267

(3023511) Choriogonadotropin [Units/volume] in Urine

100

648

1.56

4.27

1.7

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

446

1.67

4.24

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

124

843

1.48

4.24

1.1

1.56

u/ml

0.00

403

(3051101) Glucose [Moles/volume] in Cord blood

3.14

4.20

5.7

6.3

8.29

8.20

mmol/l

0.05

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

179

1308

1.38

4.14

2.0

186.92

213.21

pmol/l

2.71

167

1245

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

337

1.76

4.10

3.1

2.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

229

1.93

4.10

1.1

—

(3028433) Virus identified in Specimen by Culture

116

2.34

4.08

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

188

2.03

4.07

1.2

1.1

245.68

183.77

iu/ml

0.66

188

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

146

1033

1.43

4.07

1.1

1.73

1.96

u/ml

0.21

531

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.90

3.99

1.3

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

348

1.73

3.97

1.6

1.5

29.70

33.65

0.35

213

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

159

1148

1.40

3.96

1.5

1.3

627.39

532.91

mg/l

0.53

152

1098

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

150

2.14

3.95

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

150

2.14

3.95

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

471

1.62

3.94

1.2

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

543

1.58

3.89

1.5

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.79

3.88

2.5

2.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.45

3.87

1.8

2.3

12.16

17.84

umol/l

2.15

(3010375) cycloSPORINE [Mass/volume] in Blood

206

1.95

3.86

27.2

28.1

130.77

117.32

ug/l

0.72

165

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

213

1.93

3.86

1.6

1.8

29.98

29.63

umol/l

0.05

196

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.60

3.80

1.0

0.52

4.96

u/ml

0.72

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

134

947

1.43

3.78

1.3

1.5

—

(3017569) Oxygen content in Arterial blood

222

1.90

3.76

2.1

2.5

15.84

16.54

0.71

222

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

142

1020

1.40

3.67

1.4

1.3

3.95

3.74

mmol/l

1.22

131

969

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

512

1.57

3.66

2.2

2.4

44.63

31.40

iu/ml

0.35

(3003888) Timothy IgE Ab [Units/volume] in Serum

128

904

1.43

3.64

1.1

4.30

4.61

u/ml

0.10

461

(3012494) Peanut IgE Ab [Units/volume] in Serum

110

2.28

3.61

1.0

1.1

0.42

10.44

u/ml

0.64

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.72

3.58

1.2

1.1

19.17

25.05

u/l

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

191

1.94

3.57

1.1

1.0

107.33

97.01

0.98

152

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

104

709

1.48

3.56

1.4

0.25

0.35

nmol/l

1.13

521

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

151

2.06

3.51

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

158

2.03

3.49

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

370

1.66

3.48

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.62

3.46

1.7

2.5

0.62

1.48

mmol/l

1.27

(4024509) Urine culture

221

1717

1.30

3.45

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

159

2.02

3.44

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1297

0.67

3.41

1.5

1.6

707.71

1031.50

mu/l

2.29

1067

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

146

2.06

3.41

1.6

2.0

197.23

163.88

0.49

138

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

538

1.53

3.39

1.4

1.3

8.17

7.33

mmol/l

1.19

483

(3008536) Aspergillus sp Ab [Presence] in Serum

2.45

3.38

1.2

2.2

—

(3019150) Specific gravity of Urine by Refractometry

1034

9325

1.14

3.37

4.4

3.8

1.02

1.18

kg/l

0.50

719

6173

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

135

1838

0.73

3.34

1.2

1.1

0.69

0.64

ratio

0.41

236

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.92

3.29

1.1

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

409

1.60

3.23

1.9

1.4

—

(44806071) Cardiolipin IgM antibody measurement

2.67

3.22

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

294

1.71

3.22

1.9

3.0

242.65

218.91

e6/l

0.24

248

(3043410) Blood group antigens tested for on Red Blood Cells

103

2.24

3.21

1.8

1.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

206

1.85

3.20

1.1

1.3

385.14

352.98

u/l

0.06

193

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.34

3.19

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.80

3.18

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

130

2.08

3.17

4.3

2.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

214

1.83

3.17

2.0

2.2

9.68

8.38

mmol/l

0.76

214

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.36

3.14

1.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

111

2.17

3.12

2.7

4.2

11.05

10.32

kpa

0.29

111

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

111

2.17

3.12

2.7

4.2

4.33

4.92

kpa

2.15

111

(3023419) Bacteria identified in Sputum by Culture

517

1.52

3.11

3.3

2.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

558

1.50

3.09

6.6

6.7

11.41

11.61

mg/l

0.15

521

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

270

2185

1.25

3.07

2.6

3.6

62.34

60.22

u/ml

0.04

258

2109

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.68

3.05

4.1

5.9

39.60

50.91

ug/min

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.44

3.04

1.1

1.3

—

(3039000) Anion gap in Blood by calculation

109

776

1.41

3.03

9.5

8.0

12.06

11.41

mmol/l

0.93

103

702

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.26

3.02

1.3

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

126

2.07

3.02

1.0

1.2

110.81

109.17

0.07

120

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.34

3.01

1.1

—

(3018572) Chloride [Moles/volume] in Blood

109

777

1.41

3.01

9.5

8.0

103.83

105.18

mmol/l

1.73

103

703

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

263

1.72

2.98

1.5

2.0

2.38

1.68

u/field

0.43

145

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.85

2.97

1.2

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

138

1026

1.36

2.97

1.6

1.5

3600.82

1236.03

e6/l

0.32

105

805

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

136

1009

1.36

2.96

1.5

1.4

35.48

30.53

e6/l

0.12

742

(44806420) Estimation of glomerular filtration rate

509

1.50

2.91

3.0

2.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

128

2.04

2.91

1.0

1.1

94.94

92.24

0.19

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.39

2.87

1.0

1.2

—

mmol/l

—

(40768446) Kidney Pathology biopsy report

185

1.84

2.86

1.3

1.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

143

1.96

2.84

1.3

1.4

89.06

136.65

nmol/l

1.47

106

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

306

1.64

2.82

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

104

745

1.41

2.82

1.1

1.16

3.23

u/ml

2.88

354

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.34

2.80

1.2

0.31

0.76

iu/ml

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

238

1.73

2.80

1.2

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

2.40

2.79

1.1

75.77

79.81

ug/l

0.10

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

194

1.81

2.79

1.9

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

697

1.42

2.77

1.0

1.1

2.39

4.34

u/ml

0.82

297

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

640

1.43

2.74

1.1

2.36

3.06

—

123

(3047189) Immunofixation for 24 hour Urine

188

1.81

2.74

1.4

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.20

2.73

1.5

1.6

—

0.68

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

218

1.75

2.71

1.5

1.3

10.56

11.52

u/l

0.36

198

(3036782) Glucose [Moles/volume] in Pleural fluid

326

1.60

2.68

1.6

1.4

6.72

6.20

mmol/l

0.74

300

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

311

1.61

2.66

1.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3533

34408

1.12

2.66

31.6

18.7

332.79

332.95

g/l

0.43

3523

34243

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

335

1.59

2.65

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

335

1.59

2.65

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

335

1.59

2.65

1.1

5.96

8.52

iu/ml

0.73

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

335

1.59

2.65

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

133

1.96

2.64

1.5

2.5

0.19

0.17

e9/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

133

1.96

2.64

1.1

1.2

1000.00

927.59

titre

—

(3023410) Appearance of Cerebral spinal fluid

457

1.50

2.59

1.6

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

639

1.42

2.59

1.3

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

100

2.11

2.58

1.5

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

499

1.47

2.57

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

5.46

2.54

1.3

4.00

2.18

mmol/24h

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

355

1.56

2.53

1.7

1.2

2.33

2.04

mmol/l

0.96

334

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

108

1449

0.74

2.51

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

486

1.47

2.49

1.6

416.23

339.41

mu/l

0.46

384

(3011412) CD3 cells [#/volume] in Blood

421

1.50

2.48

1.8

2.6

1431.00

1221.86

e6/l

1.07

371

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.98

2.48

1.2

1.37

1.66

iu/ml

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.38

2.47

1.0

1.1

0.05

0.03

u/ml

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

195

1.75

2.46

1.8

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

195

1.75

2.46

1.8

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

195

1.75

2.46

1.8

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

195

1.75

2.46

1.8

1.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.67

2.45

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.46

2.44

1.3

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

117

878

1.34

2.43

1.1

1.00

1.08

u/ml

0.07

363

(3028679) Herpes simplex virus Ab [Presence] in Serum

257

1.64

2.41

1.1

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.29

2.41

1.1

0.03

5.55

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

835

0.67

2.40

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

124

1.94

2.40

1.0

1.3

93.00

92.45

0.03

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

153

1942

0.78

2.39

1.2

1.1

1.45

1.52

g/l

2.59

153

1942

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

160

1.82

2.39

6.4

4.5

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

6.26

2.37

1.4

1.0

—

(3018291) Platelet Ab [Presence] in Serum

6.26

2.37

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

290

1.59

2.36

1.9

2.8

537.86

559.55

e6/l

0.11

234

(3001556) Androgen free Index in Serum or Plasma

2.61

2.35

1.4

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

2.50

2.35

1.4

—

(3004451) EKG impression Narrative

213

1.70

2.35

1.1

1.3

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.82

2.34

1.0

0.10

1.00

u/ml

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.82

2.34

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

108

807

1.35

2.32

1.3

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

461

0.56

2.31

1.4

1.5

44.04

59.30

ug/l

1.75

461

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

663

1.38

2.29

1.3

1.4

25.82

29.69

u/l

0.48

540

(3012441) Differential panel - Pleural fluid

332

1.54

2.29

1.8

1.5

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.89

2.25

1.0

0.00

0.56

u/ml

—

(3039443) Prostate specific Ag panel - Serum or Plasma

869

0.69

2.24

1.3

1.6

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

3.11

2.22

1.0

1.3

73.89

2828.54

u/l

—

(3045142) Bone marrow Pathology biopsy report

458

1.45

2.20

1.2

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

304

1.55

2.18

1.1

—

1.48

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.50

2.18

1.1

0.04

0.03

u/ml

0.55

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

158

1.78

2.17

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

427

1.46

2.15

1.9

1.5

33.10

33.96

g/l

0.18

383

(40768795) Lymph node Pathology biopsy report

411

1.47

2.14

1.3

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

2.05

2.11

1.2

1.3

115.05

58.44

mu/l

0.74

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

331

1.52

2.11

1.5

2.3

—

(3042517) Benzodiazepines panel - Urine

2.56

2.07

5.2

2.2

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

5.00

2.07

1.4

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

5.00

2.07

1.4

1.0

—

(4015189) Microbial culture of sputum

2.08

2.06

1.9

2.5

—

(3006462) Nitrate [Presence] in Urine

146

1.79

2.06

4.1

3.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

269

1.57

2.05

2.3

1.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.50

2.05

34.6

8.6

101.43

106.45

g/l

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.50

2.05

7.3

10.8

—

(3033099) Centromere Ab [Titer] in Serum

1.98

2.05

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

4.00

2.04

1.0

1.6

2.54

2.14

nmol/l

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.82

2.00

1.3

1.4

390.89

350.59

umol/24h

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

655

1.35

1.99

1.0

1.1

0.06

0.23

u/ml

1.85

201

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

148

1.76

1.98

1.9

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

411

1.44

1.96

2.7

2.2

18.04

21.16

mg/l

0.24

149

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

370

1.47

1.95

3.1

4.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

164

1.71

1.94

2.4

3.0

1.16

1.36

0.18

164

(3034426) Prothrombin time (PT)

149

1.75

1.94

1.4

1.2

27.42

29.02

0.73

149

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

180

1.67

1.91

1.5

1.7

2.28

2.83

u/field

0.16

134

(3005033) Fetal Nuchal fold Thickness US

569

0.65

1.91

1.3

1.5

1.14

1.28

1.84

402

(3047352) Trisomy 18 risk [Likelihood] in Fetus

581

0.65

1.91

1.3

1.5

—

(4211845) Urine protein measurement

165

1.70

1.90

3.9

3.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

275

1.53

1.89

1.0

1.1

6.28

4.66

nmol/l

0.09

(3045683) HLA typing for celiac disease panel - Blood or Tissue

267

1.54

1.89

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

2.12

1.81

1.7

2.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

556

5017

1.12

1.80

1.5

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.06

1.80

1.1

1.2

0.87

7.10

u/ml

0.44

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

1.74

1.79

1.3

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

748

0.71

1.78

1.4

1.5

48.51

60.59

ug/l

1.45

615

(4094501) Cardiovascular stress test using bicycle ergometer

156

1273

1.23

1.77

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

101

782

1.30

1.77

1.1

22.07

15.61

au/ml

0.25

222

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

2.34

1.77

4.4

2.4

55.61

75.71

pmol/l

0.32

(3043238) Trisomy 21 risk [Likelihood] in Fetus

594

0.67

1.76

1.4

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

232

1.56

1.75

1.3

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

240

1.55

1.75

2.2

2.0

87.94

113.63

ng/l

1.57

240

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.98

1.74

1.5

1.4

1.18

mmol/l

0.01

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

686

0.70

1.74

1.3

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

672

1.32

1.72

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

695

0.70

1.70

1.3

1.4

0.94

0.95

ratio

0.12

416

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

695

0.70

1.70

1.3

1.4

1.22

1.17

ratio

0.11

417

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

695

0.70

1.70

1.3

1.4

0.93

1.16

ratio

1.24

416

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

148

1.69

1.70

1.9

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

148

1.69

1.70

1.9

2.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

156

1.67

1.68

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

325

1.45

1.66

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

180

1.62

1.66

1.1

1.2

—

(44790047) Parainfluenza type 1 nucleic acid detection

537

1.35

1.66

1.3

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

537

1.35

1.66

1.3

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

537

1.35

1.66

1.3

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

537

1.35

1.66

1.3

1.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.80

1.65

1.0

0.02

0.16

u/ml

—

(3024263) Appearance of Synovial fluid

204

1.57

1.65

1.9

1.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

130

1050

1.25

1.64

1.3

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.03

1.64

1.0

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.38

1.61

1.0

0.04

10.19

u/ml

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

143

1.68

1.60

1.1

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.33

1.58

1.0

0.05

0.48

u/ml

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.69

1.58

4.3

6.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

240

1.50

1.54

1.3

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

281

1.46

1.54

1.0

1.1

0.79

0.80

u/ml

0.00

(3035880) pH of Pleural fluid

153

1.64

1.53

1.7

1.4

7.41

7.39

0.31

106

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.34

1.52

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

550

0.69

1.51

2.2

1.8

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

108

1.76

1.50

1.2

10.84

11.31

pmol/l

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

443

1.36

1.50

1.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.44

1.47

1.6

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

166

0.48

1.46

1.1

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

1.47

1.45

1.3

1.6

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.50

1.45

1.0

1.4

—

(3007456) Orange IgE Ab [Units/volume] in Serum

3.13

1.44

1.2

1.0

0.06

0.10

u/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

327

0.61

1.41

1.4

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

393

4362

0.89

1.40

8.2

6.3

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.18

1.39

1.3

1.8

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

330

1.40

1.38

1.4

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

759

7063

1.09

1.37

2.9

0.67

0.71

ug/l

0.24

471

4114

(3001964) Herpes simplex virus Ag [Presence] in Specimen

119

1.68

1.37

1.2

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.13

1.33

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.97

1.32

9.4

10.0

5.20

5.96

mmol/l

0.54

(40768806) Pleura Pathology biopsy report

333

1.39

1.32

1.7

1.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

121

1.66

1.30

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

121

1.66

1.30

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

121

1.66

1.30

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

121

1.66

1.30

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.10

1.30

1.2

1.1

1.96

1.74

umol/24h

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.76

1.28

19.7

7.8

5.51

5.39

kpa

0.08

(3007463) Buprenorphine [Presence] in Urine

2.78

1.28

6.2

6.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

114

1.67

1.28

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.29

1.26

2.1

2.6

0.38

0.57

u/field

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

405

1.34

1.26

1.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

115

1.65

1.24

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

761

1.24

1.23

4.6

3.4

22.35

25.04

mg/l

0.34

507

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.23

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

100

1.70

1.23

1.5

1.1

—

(3018133) Calcium [Moles/volume] in Urine

1.77

1.22

1.9

2.1

2.59

2.94

mmol/l

0.38

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

313

1.38

1.22

1.1

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

383

1.34

1.19

1.8

1.5

9575.18

4559.39

e6/l

0.25

268

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.70

1.17

1.4

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.05

1.15

1.1

1.2

—

619.04

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

142

1.55

1.14

1.2

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

151

1.53

1.11

2.3

2.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.96

1.11

1.2

1.0

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

495

1.28

1.09

1.1

—

6.04

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.38

1.09

1.0

1.1

—

31.40

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

104

1.64

1.09

1.3

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

1.95

1.08

1.0

1.3

—

(3025130) Human papilloma virus identified in Specimen

639

1.24

1.08

1.5

1.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

330

1.34

1.06

1.8

1.5

21025.09

88369.82

e6/l

1.65

186

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.93

1.06

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.27

1.03

7.0

1.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

475

1.27

1.00

1.1

—

59.50

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.00

1.00

1.0

0.02

3.23

u/ml

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.85

0.96

1.1

1.0

—

(3045788) Cell count panel - Pleural fluid

319

1.32

0.96

1.7

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

141

1.49

0.94

2.5

2.6

26.84

29.36

umol/l

0.37

(3044009) aPTT.lupus sensitive (LA screen)

1.89

0.94

1.0

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.89

0.94

1.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.22

0.93

1.0

0.02

0.19

u/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

969

9239

1.06

0.93

4.0

3.9

22.96

21.51

1.79

371

3993

(4212803) Bone marrow aspirate examination

2.14

0.91

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.00

0.87

3.5

2.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

136

1.47

0.86

1.3

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.67

0.85

1.3

1.2

60.83

65.26

ug/l

0.41

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

611

0.80

0.82

1.4

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.82

0.79

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.67

0.78

1.9

1.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.78

0.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

226

1.33

0.76

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.70

0.75

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.70

0.75

1.2

—

(44786800) Granulocytes/Leukocytes in Body fluid

2.08

0.74

1.2

1.3

31.80

36.60

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

278

2557

1.09

0.74

2.3

2.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

132

1492

0.88

0.74

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

416

1.23

0.71

4.5

5.4

57.88

63.66

u/ml

0.05

130

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

220

1.32

0.71

1.2

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

206

0.68

0.71

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.55

0.69

1.8

2.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

1.46

0.68

1.2

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

365

1.24

0.67

1.2

41.13

40.88

mg/l

0.01

309

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

102

1.47

0.67

1.1

—

(44813793) Dust mix specific IgE antibody measurement

303

1.26

0.66

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

120

1.42

0.64

1.2

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

278

1.26

0.63

1.0

0.31

1.82

u/ml

0.89

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.50

0.63

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

181

1.33

0.63

1.6

2.0

32.29

31.03

0.16

181

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

434

1.20

0.61

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.51

0.58

1.9

2.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

754

1.14

0.57

1.5

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

310

1.23

0.56

1.1

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

150

1.33

0.55

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

312

1.22

0.54

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

204

1.28

0.54

1.4

1.3

5.67

5.87

mmol/l

0.46

195

(4027681) Cerebrospinal fluid IgG ratio and IgG index

267

1.24

0.53

1.3

1.2

0.63

0.56

ratio

0.31

162

(3005011) Chlamydia sp Ab [Titer] in Serum

1.43

0.52

1.8

1.5

—

(40768800) Prostate Pathology biopsy report

662

0.86

0.52

1.3

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

132

0.68

0.51

6.0

6.2

12.56

7.77

—

132

(40761995) Spermatozoa Progressive [#/volume] in Semen

132

0.68

0.51

3.0

3.1

44.78

45.24

—

132

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

260

1.23

0.51

2.8

2.9

41.42

42.76

0.14

134

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.46

0.50

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.49

0.49

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

371

1.19

0.49

1.4

132.43

193.20

pmol/l

1.48

371

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

101

1.39

0.49

1.1

1.4

48.25

33.24

—

(3010503) CD19 cells [#/volume] in Blood

262

1.22

0.48

2.3

2.6

169.38

242.16

e6/l

0.32

256

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

228

2130

1.07

0.48

2.3

2.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

389

3701

1.06

0.46

1.9

1.8

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

227

1.23

0.46

1.4

1.2

15.29

9.25

mm/h

1.40

227

(4034850) Laboratory test

115

1258

0.91

0.43

14.5

9.3

—

(4038314) Semen analysis, post vasectomy

1.56

0.42

1.4

1.2

—

(40758358) Immune stain study

0.00

0.41

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

2.05

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

106

1.32

0.39

1.0

13.68

37.58

iu/ml

2.27

106

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.34

0.38

8.1

7.8

10.18

10.39

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

116

0.69

0.36

1.1

1.3

55.00

50.49

—

102

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

387

1.14

0.33

1.4

1.5

3.84

4.31

ug/l

0.18

325

(3012898) Urea [Moles/volume] in Urine

1.30

0.33

1.2

1.3

212.17

169.08

mmol/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

341

1.14

0.32

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

239

1.17

0.31

13.3

7.1

54.08

160.93

u/ml

0.71

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.32

0.30

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.27

0.30

1.1

—

(40768793) Breast Pathology biopsy report

106

987

1.08

0.29

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

291

0.86

0.28

1.0

30.31

41.45

ng/l

0.74

207

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.27

0.27

1.3

2.6

1.19

mmol/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

252

1.15

0.27

1.0

1.1

1628.03

1488.71

miu/ml

0.33

252

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.23

0.27

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

289

0.86

0.26

1.0

219.65

310.25

ng/l

1.38

211

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

289

0.86

0.26

1.0

944.44

777.49

ng/l

0.83

204

(3024869) Neuronal Ab [Presence] in Serum

1.19

0.26

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

896

1.07

0.26

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

896

1.07

0.26

1.1

—

(40757373) Influenza virus identified in Isolate

1.23

0.25

1.2

1.9

—

(40765096) Chromosome analysis panel by Banding

142

1.20

0.24

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.73

0.24

1.0

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

266

1.13

0.22

1.0

0.46

1.77

u/ml

0.43

(40758292) HTLV I+II Ab panel - Serum

0.77

0.22

1.1

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.25

0.22

1.0

1.1

83.20

76.80

titre

—

(3019174) dRVVT (LA screen)

1.22

0.22

1.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.21

0.0

5.7

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

3.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.22

0.20

10.5

10.6

0.22

0.20

—

(1761868) Lipid panel - Serum or Plasma

1787

17717

1.01

0.18

4.1

3.0

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

110

1.18

0.17

1.9

1.5

65.23

58.33

0.31

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.18

0.16

3.0

1.8

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.18

0.16

3.1

3.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

120

1.17

0.16

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

102

1.18

0.15

1.3

3.5

91.28

149.67

ng/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

635

6440

0.98

0.14

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

266

1.09

0.14

1.1

1.04

1.10

u/l

—

121

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

122

1.15

0.13

3.1

3.4

2.38

2.10

ratio

0.28

113

(4133840) Spirometry

128

0.86

0.13

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

269

1.08

0.11

6.8

7.1

3.05

155.19

ug/l

1.13

170

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

135

1.11

0.09

1.9

1.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

340

1.06

0.09

1.1

20.55

19.27

u/ml

0.09

140

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.11

0.09

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.03

0.08

2.2

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

113

0.88

0.08

1.7

1.6

0.68

0.48

e9/l

—

113

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.83

0.08

1.6

2.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.05

0.07

1.5

1.4

—

(3006270) Folate [Moles/volume] in Blood

284

1.06

0.07

1.1

379.04

389.34

nmol/l

0.09

259

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.85

0.07

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.85

0.07

1.0

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

363

1.05

0.07

1.3

1.4

9093.88

67828.81

e6/l

1.76

252

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

101

0.89

0.06

1.0

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

193

0.93

0.06

3.1

2.5

57.23

51.00

umol/l

0.27

174

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

190

0.95

0.04

1.1

22.20

352.07

ng/l

—

(3020650) Glucose [Presence] in Urine

142

1.06

0.02

1.6

1.7

0.07

0.04

estimate

0.13

142

(3001019) Free T4 and TSH panel - Serum or Plasma

244

2454

0.99

0.02

1.6

1.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

113

0.97

0.00

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

156

1557

1.00

0.00

1.9

—

30.85

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.90

0.00

1.3

2.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.40

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.00

-0.00

1.1

3.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

5.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.94

-0.00

1.2

1.0

14.65

6.59

u/ml

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

2.2

—

2.60

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

0.77

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.93

-0.00

1.2

1.1

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

8.31

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.90

-0.00

1.7

1.8

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

6.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint NAFLD and mortality.

Females

Parameter	HR [95% CI]	p-value
NAFLD	2.01 [1.77, 2.28]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.127

During the follow-up period (1.1.1998 — 31.12.2019), 867 out of 7023 females with NAFLD died.

Males

Parameter	HR [95% CI]	p-value
NAFLD	2.179 [1.91, 2.48]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1066 out of 7507 males with NAFLD died.

Mortality risk

Mortality risk for people of age

years, who have NAFLD.

N-year risk	Females	Males
1	0.139%	0.401%
5	1.033%	2.268%
10	2.558%	5.635%
15	5.085%	10.176%
20	9.129%	16.963%

Relationships between endpoints

↥

Index endpoint: NAFLD – Nonalcoholic fatty liver disease

GWS hits: 8

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Nonalcoholic fatty liver disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints